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 « Il faut savoir s'instruire dans la gaieté. 
 Le savoir triste est un savoir mort. L'intelligence est joie. » 
 
"Learning should be a cheerful process.  
Sad knowledge is dead knowledge. Intelligence is joy.” 
 
De Voltaire
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1. Adult neurogenesis 
For long time scientists assumed that neurogenesis was restricted to embryonic and 
early postnatal development period in our central nervous system (CNS). Since two 
decades several key findings - such as the remodeling of vocal centers in singing 
birds each year through new born neurons and the isolation and culture of neural 
cells with undifferentiated cells properties - consolidated the discovery of newly 
generated and integrated neurons during adult life.  
1. Adult neurogenesis in human and rodent brain 
Adult neurogenesis is a particular form of neural plasticity described in many brain 
regions of multiple species such as birds, reptiles, fish and mammalian brain, 
including human. In adult mammalian brain the subgranular zone (SGZ) of the 
hippocampal dentate gyrus (DG) and the subventricular zone (SVZ) of the lateral 
ventricle are the two major niches of neural stem cells where a basal level of 
neurogenesis is described (Kempermann and Gage 1999, Kempermann et al., 2003, 
Zhao et al., 2008). In rodent brain thousands of neural progenitors are produced on 
a daily basis in the SVZ and migrate along the rostral migratory stream (RMS) 
towards the olfactory bulb (OB) where they differentiate into local interneurons 
(Malvaut et al., 2016). In the SGZ newly born neurons are integrated in the DG and 
play a physiological role in hippocampal function (Zhao et al., 2008). 
Retrospective birth dating by 14C incorporation in CNS neurons showed that one 
third of human hippocampal neurons are subjected for turn over during life time. 
The extent of hippocampal neurogenesis between middle aged human and middle 
aged mice was comparable (Spalding et al., 2013). The importance of adult 
neurogenesis is different between rodents and human. While it is pronounced in 
both DG and OB of rodent brain, only DG neurogenesis appears to be substantial in 
human brain (Bergmann et al., 2012, Spalding et al., 2013). A considerable level of 
newly generated neurons was also described in other brain regions such as 
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neocortex (Gould et al., 2007) hypothalamus (Kokoeva et al., 2005) and human 
striatum (Ernst et al., 2014). However, the role of adult neurogenesis outside the 
SGZ and SVZ remains to be fully described.  
2. Hippocampal neurogenic niche and neurogenesis process 
Adult CNS “stem cells” exhibit three prime features: (i) they are self-renewing, 
with the ability to regenerate progeny identical to themselves, (ii) proliferative, 
undergoing mitosis with long cell cycle and (iii) multipotent, able to generate 
neuronal and glial lineages cells. Adult hippocampal Neural Stem Cells (ahNSC) 
reside in a unique microenvironment called neurogenic niche confined within the 
SGZ hilus region. The neurogenic niche is a complex zone composed of NSC 
surrounded by ependymal cells, astroglial cells, vessels and mature neurons (Fig. 
1). Diffusible molecule and cell-cell contacts within the niche and from outside can 
influence NSC proliferation, differentiation and survival (Alvarez-Buylla et al., 
2004, Quinones-Hinojosa at al., 2006). The generation of new neurons is a 
complex multistep process (Fig. 2) that involves a series of developmental phases 
before the complete maturation and functional integration into neuronal networks 
(Fig. 2, A). Cellular maturation phases could be identified by morphological 
characteristics as well as the expression of specific molecular markers (Fig. 2, B). 
In the SGZ, dormant radial glial-like cells have processes spanning the granule 
layer and the inner molecular layer of the hippocampus. They express glial 
fibrillary acidic protein (GFAP), Sry-related HMG box transcription factor (Sox2), 
nestin (nerve cells intermediate filament) (GFAP+, Sox2+, nestin+, S100β−) and are 
negative for the astroglial marker S100β (Filipov et al., 2003). They are usually 
referred as type 1 cells or NSC. By asymmetric division, a NSC gives rise to an 
identical progeny that remains in quiescent state and to a transiently amplifying 
neural progenitor cell (NPC).  
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NPCs are non-radial cells with short processes positioned tangentially to the 
granular layer. They are GFAP-, S100β−, Sox2+, Nestin+ highly proliferative and 
referred to as type 2 cells (Kronenberg et al., 2003). NPCs generate neuronal 
progenitors expressing doublecortin (DCX) and polysialylated-neural cell adhesion 
molecule (PSA-NCAM) named neuroblasts type 3 cells, and a population of glial 
progenitors GFAP+, S100β+ (Ma et al., 2009, Bonaguidi et al., 2012). Immature 
newborn neurons (DCX+) migrate a small distance in the granule cell layer (GCL) 
of the DG and start to receive synaptic inputs from existing neuronal circuits. The 
surviving cells continue their maturation and have more complex apical dendrites 
connecting the enthorinal cortex and hippocampal cornu ammonis (CA3) subfield. 
Mature neurons express neuronal nuclear antigen (NeuN) and Calbindin (Fig. 2 B). 
It takes roughly 1-2 months for newly generated neurons to reach morphological 
maturity and functionally integrate in neuronal networks (Fig. 2) (Lucassen et al., 
2010).  
Figure 1.  Schematic representation of the 
cytoarchitecture in the hippocampal 
neurogenic niche. A. Coronal section of 
adult mouse brain showing the localization 
of the subgarnular zone (SGZ) in the 
hippocampus. B. Cell population in the 
dentate gyrus (DG) of the mammalian 
brain. GCL: Granular cell Layer; IML: 
Inner Molecular Layer. (Modified from 
Donegà et al. 2013) 
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In the early 1990s several laboratories concomitantly showed that NSC could be 
isolated from adult brain and expanded in vitro in presence of growth factors. 
Isolated stem cells in presence of epidermal growth factors (EGF) formed spheres 
after days in proliferation and expressed nestin (Colucci-D’Amato et al., 2006; 
Reynolds and Weiss, 1992). The in vitro model of stem cells deriving from brain 
tissue and specifically from the hippocampus was validated and well characterized 
over the years in our and other research groups. It is used as a tool to identify 
molecular events underlying adult hippocampal neurogenesis and its possible 
modulators.  
3. Adult hippocampal neurogenesis modulators  
Proliferation of ahNPC, complete maturation, integration into neuronal circuits and 
spines development of newly generated neurons are plastic processes strongly 
regulated by neuronal network activity, cell-cell interactions, endogenous and 
exogenous modulators (Fig. 3).   
1. Network activity and neurotransmitters 
Enriched environment (EE) and voluntary exercise increase the DG network 
activity and result in Gamma-Aminobutyric acid (GABA) spill over from local 
GABAergic synapses into the neurogenic niche. Nestin+ quiescent NSCs in the 
SGZ respond to spilled GABA through GABAA receptors containing the γ2 
subunit. GABA halts the proliferation and favors the differentiation and maturation 
of new neurons (Dranovsky et al., 2011). One peculiarity of newborn DCX+ young 
neurons is having high chloride levels due to high expression of chloride importer 
(NKCC1) that are lost with maturation and replaced by chloride transporter 
(KCC2). 
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Figure 2. Representative scheme for the phases and hallmarks of adult hippocampal 
neurogenesis. A. Summary for the different phases of hippocampal neurogenesis. 1. Expansion 
by activation of radial glia-like cells and proliferation of intermediate adult hippocampal neural 
progenitor cells (ahNPC). 2. Differentiation toward immature neurons (neuroblasts). 3. 
Integration into the dentate gyrus networks (Cornu ammonis, CA3) and maturation of young 
granule neurons. B. Different markers are expressed by ahNPC at different phases of maturation. 
Immature cells markers (GFAP, Nestin, and Sox-2); neuroblasts markers (DCX, PSA-NCAM 
and Tuj-1); mature neurons markers (NeuN and Calbindin). C. Time scale of the different steps 
of maturation. (Modified from Schouten et al., 2012). 
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EE increases the level of stimulatory neurotransmitter glutamate in the synapses. 
Newly generated neurons express NMDA glutamate receptors with NR2B subunit. 
This particular feature facilitates long term potentiation (LTP) induced by 
glutamate that enhances the maturation, integration and survival of new neurons 
(Ge et al, 2007). In summary, intrinsic cell properties and network activity dictate 
the quality and/or the quantity of the proliferation of ahNPC and the maturation of 
young neurons.  
Major CNS neurotransmitters such as acetylcholine (ACh), dopamine (DA), 
norepinephrine (NE) and serotonin (5-HT) modulate neurogenesis. The cholinergic 
system has a substantial role in the hippocampal functions and is one of the major 
candidates suggested to influence adult neurogenesis. Indeed the ablation of basal 
forebrain in adult rats (cholinergic center) decreased the number of double labeled 
cells for 5-bromo-2-deoxyuridine BrdU (DNA intercalant during proliferation) and 
NeuN (mature neurons) in the SGZ (Cooper-Kuhn et al., 2004). Dopaminergic 
axons originate from ventral tegmental area (VTA) and the adjacent substantia 
nigra to innervate the DG (Mu et al., 2011). The hallmark of Parkinson’s disease is 
cerebral dopamine depletion. Indirect studies on the brain of patients or rodent 
models of Parkinson’s disease were used to study the effect of dopamine on adult 
neurogenesis. The proliferation of ahNPC is reduced in the SGZ in dopamine 
depleted brains (Höglinger et al., 2004). Noradrenergic innervation of the DG 
originates from the locus coeruleus. Lesions of NE projecting fibers decreased 
neurogenesis considerably (Kulkarni et al., 2002). Intra-hippocampal injection of 
NE and β3-adrenergic receptor (β3-AR) agonist increased the proliferation and the 
number of nestin+/GFAP+ neural precursors (Jhaveri et al., 2010). A more recent 
study suggested that NE increase ahNPC proliferation through β2-AR (Masuda et 
al., 2012). Serotonin is synthesized in the brain stem raphe nuclei and serotonergic 
fibers project into the DG of the hippocampus where they connect with granule 
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cells and interneurons (Alenina and Klempin, 2015). The role of serotonin in adult 
hippocampal neurogenesis will be detailed in a separate paragraph (II.3). 
2. Astrocytes  
 
 
 
 
 
 
 
With regard to the importance of astrocytes in the CNS, Nedergaard and Goldman 
stated that "astrocytes might serve neurons not so much as servants but as parents 
… astrocytes tell neurons what to do beside just cleaning up their mess" 
(Nedergaard et al., 2003). Astrocytes are the most abundant cell population in the 
CNS and the major components of the neurogenic niche (Song et al., 2002). 
Traditionally astrocytes were assigned only a supportive and trophic role in all 
brain functions (Pixley, 1992). After years of research now astrocytes are 
acknowledged aside from the trophic role also for their major contribution to 
embryonic and adult neurogenesis (Gomes et al., 2001).  Specifically, astrocytes 
through the release of  diffusible signals and also direct contact to neurons play a 
role in neuronal differentiation, synapse formation, axonal guidance and 
electrophysiological properties regulation (Pfrieger and Barres 1997; Lim and 
Alvarez-Buylla 1999; Song et al. 2002). In particular, hippocampal astrocytes are 
the energy providers during memory formation. The lactate hydrogenase provided 
by astrocytes sustains the long term potentiation (LTP) and memory retention in 
the hippocampus (Suzuki et al. 2011). Astrocytes have intercellular crosstalk 
between themselves, neurons, microglia cells and endothelial cells. Importantly, 
astrocytes communicate bidirectionally with neurons by the tripartite synapse, a 
structure where astrocytes are associated with presynaptic and postsynaptic neurons 
membrane. The interaction is physical and functional since astrocytes function is 
dependent on neuronal activity (reviewed in Pekny et al., 2016). Astrocytes employ 
several molecular mechanisms such as exocytosis, diffusion through cellular 
membrane and membrane transporters to release numerous neurotransmitters and 
trophic factors. These elements are signals to neurons and microglial cells that 
regulate the synaptic and neuronal activity (Newman, 2003). For example, 
CHAPTER I: INTRODUCTION 
 
20 
 
thrombospondin is an extracellular glycoprotein secreted by astrocytes and 
specifically upregulated after an ischemic injury. Astrocytes through 
thrombospondin control the post-ischemic angiogenesis and synaptic reformation 
(Liauw et al., 2008).   
 
 
 
 
 
 
In addition to their role in physiological and pathological conditions in the CNS 
astrocytes are also important contributors to adult neurogenesis specifically in the 
hippocampus. Song and colleagues showed that co-culture of hippocampal NPCs 
Figure 3. Adult hippocampal neurogenesis is modulated by several endogenous and 
exogenous factors. The different phases of neurogenesis could be increased by several 
modulators such as neurotransmitters, growth factors, environment and learning (Green factors) 
or decreased by stress, drugs and aging (Red factors) (Modified from Koehl, 2015).   
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and astrocytes promoted the proliferation of NPCs and favored their differentiation 
toward the neuronal lineage. An intriguing outcome of this study was that 
astrocytes originating from the spinal cord did not have neurogenic effect, therefore 
the neurogenic potential could be niche specific (Song et al., 2002). Another study 
showed that astrocytes coming from proneurogenic regions secreted cytokines and 
chemokines such as IL-1β and IL-6 that promoted neuronal differentiation at low 
concentrations (Barkho et al., 2006). Additionally, astrocytes through Wnt 
signaling regulate the expression of transcription factors such as: (i) Prox1 that has 
a role in the proliferation of NPCs and maturation of newly generated neurons and 
(ii) NeuroD1 that is crucial for survival and maturation of new neurons (Karalay 
and Jessberger, 2011).  
3. Extrinsic and environmental regulators 
Neurogenesis is also regulated by behavioral and environmental positive 
modulators such as voluntary exercise/running, EE, learning and negative 
modulators such as stress, aging and drug of abuse (Kempermann and Gage, 2000). 
Running is one of the most potent inducers of neural progenitor cell proliferation. It 
dramatically increases the number of BrdU positive (BrdU+) cells in the DG of 
adult mice. Additionally, running increases the survival of newborn neurons after 4 
weeks from exercise and synaptic plasticity since it enhances LTP in the DG (Van 
Praag et al. 1999 a,b). EE has a complementary effect increasing the survival of 
neurons at a critical stage of their maturation (Kobilo et al., 2011). For example, 
running itself increases the number of BrdU+ cells. Subsequent learning increases 
the number of BrdU+/NeuN+ and Tuj-1+ after 4 weeks from running. Hence 
learning rescues immature neurons from death and favors integration in the DG 
neuronal circuits (Leuner et al., 2004; Shors, 2008). Increased number and survival 
of 1- to 3-week-old newborn neurons are influenced by spatial learning and 
exposure to EE (Kee et al., 2007; Tashiro et al., 2007; Vivar et al., 2013). In 
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contrast, stress and aging are severe negative regulators of proliferation and 
differentiation (Kempermann, 2000). Proliferation in the DG is drastically reduced 
in aged (21 month-old) rats compared to middle-aged (6 month-old) rats (Kuhn et 
al., 1996). Reduced proliferation resulted in a decreased number of new neurons 
(eight to nine folds) from middle-aged to aged rats, indicating a dramatic decrease 
in neurogenesis associated with aging (Heine et al., 2004).   
4. Role in physiology and changes under stressful conditions 
The DG network activity regulates de novo neurogenesis and the post-mitotic 
neurons contribute to hippocampal dependent learning, memory and behavior 
(Kempermann et al., 1997, Gould et al., 1999). The dorsal hippocampus has a 
preferential role in learning and memory, whereas the ventral hippocampus is 
involved in affective behavior (Bannerman et al., 2004). For example, Morris 
Water Maze (MWM) learning tasks (conventional paradigm to assess spatial 
learning) increased the number of BrdU+/DCX+ cells along the SGZ of the DG. 
These young neurons had more complex and a higher number of DCX+ 
arborizations (Tronel et al., 2010). Furthermore, learning elicits different influences 
on neural precursors at different developmental stages. For instance, in contrast to 
the 7-day old cells, the survival of 3-day old newborn cells is inhibited by MWM 
training (Dupret et al., 2007). This implicated that there is a selective integration of 
newborn neurons in spatial learning and memory. Stress reduces neurogenesis and 
MWM learning capacity. This effect was reversed by housing the mice in EE cages 
that normalized the number of BrdU+ in the hippocampal DG and restored spatial 
learning in MWM (Nilsson et al., 1999; Veena et al., 2009). Among the elements 
of EE, the use of running wheels was the most effective in increasing BrdU+ 
ahNPC after 24 h and BrdU+/Calbindin+ new neurons after 4 weeks. Increased 
neurogenesis was correlated with improved performance in MWM tasks 
(Kempermann et al., 1997). Moreover, running increases the level of brain derived 
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neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) and 
induces LTP in the hippocampus (Vivar et al., 2013; Kronenberg et al., 2003). 
Supporting the role of active adult neurogenesis in hippocampal-dependent tasks, 
the age-related reduction of hippocampal neurogenesis was also paralleled with 
MWM learning and memory deficits (reviewed by Lieberwirth et al., 2016).  
Despite its extensive characterization in rodents, the functions of adult 
hippocampal neurogenesis in human CNS remain a big question. Several 
researchers suggested that adult hippocampal neurogenesis might have an 
important role in hippocampal-dependent contextual pattern discrimination. 
Computational modeling suggests that new stimuli cause the inhibition of old 
consolidated networks and the activation of new ones. This network remodeling is 
potentially mediated by newly integrated interneurons that play a role in higher 
pattern separation capacity between very similar memories and contexts (Bakker et 
al., 2008; Sahay et al., 2012). 
Adult hippocampal neurogenesis (ahNG) is affected diversely in several CNS 
disorders. It is downregulated in mood disorders, specifically major depression 
disorder (MDD), epilepsy, stroke, and Parkinson disease (Kempermann et al., 
2008). In contrast, cell proliferation was increased in the SVZ and SGZ of 
Alzheimer’s patients and the SVZ of Huntington’s patients postmortem brains 
(Zhao et al., 2008). Adult neurogenesis alterations could not explain the entire 
pathophysiology of neuropsychiatric disorders such as depression, schizophrenia 
and dementia. However, it was strongly correlated to hippocampal related 
impairments such as memory loss, difficulties in learning and increased incidence 
of depression (Kempermann et al., 2008). In 1992, Gould and colleagues were the 
first to correlate the decrease of ahNPC proliferation in the SGZ and elevated levels 
of stress hormones in the plasma of adult rats (Gould et al., 1992). Restraint and 
immobilization used as stressor in rodents inhibited the proliferation of NPC and 
reduced the survival of newly generated PSA-NCAM cells, therefore resulting in a 
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decrease of the DG volume and GCL thickness (Lee et al, 2009; Pham et al., 2003). 
The odor of predators, a natural stressor, is also shown to rapidly decrease the 
number of BrdU-labeled cells in the SGZ. Moreover, there was also a decrease in 
the percentage of NeuN+ neurons at 3 weeks after the odor exposure (Zhao et al, 
2007). Similarly, chronic unpredictable mild stress (UCMS) (a paradigm used to 
induce depressive-like behavior in rodent) decreased also Ki67+ cells (endogenous 
marker for proliferation) and young neurons survival in the DG (Heine et al., 
2004). In summary, psychological stress that causes depressive state decreased 
neurogenesis at different levels: proliferation rate of NPC, survival of young 
neurons (neuroblasts) and the number of mature neurons (Kempermann, 2002). 
2. Serotonin 
1. Serotoninergic circuit and receptor expression in the CNS  
Serotonin (5-hydroxytryptamine, 5-HT) was first discovered in mid-thirties by the 
pharmacologist V. Erspamer in the gastrointestinal tract and the blood. Serotonin 
induced smooth muscle fibers contraction, thus it was first described as 
vasoconstrictor, hence the name serotonin (serum that gives tone) (Rapport et al., 
1948). Particularly during early embryonic development 5-HT is secreted by the 
placenta and enters the fetus blood stream. It is one of the first and essential 
signaling cues in the embryonic brain developmental stages (Bonnin et al., 2011). 
In mammals, including human, serotonin is synthesized from the amino acid L-
tryptophan by two enzymes: tryptophan hydroxylase (TPH) and aromatic amino 
acid decarboxylase (DDC). TPH enzymes exist in two forms: TPH1, found in 
several tissues and TPH2 that is a neuron-specific isoform (Walther et al., 2003). 
The peripheral and central brain serotonin systems are separated but equally 
important for several physiological functions. Peripherally 5-HT is important for 
energy balance, food intake, gastrointestinal tract, cardiovascular system. Centrally 
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5-HT is involved in behavioral and neuropsychological processes including mood 
perception, reward, anger, aggression, appetite, memory, sexuality and attention 
(Berger et al., 2009). 
While it was thought that 5-HT is exclusively produced in raphe nuclei (RN) 
neurons located in the midline of the brainstem, recent in situ hybridization 
experiments showed that TPH2 is also expressed in the hippocampus and the 
striatum (Gutknecht et al., 2009). Serotoninergic neurons are the most abundant 
and complex system in the brain since they innervate almost all brain regions. They 
are among the earliest differentiated neurons found in a variety of organisms from 
C. Elegans to vertebrates (Lesch and Waider, 2012). Serotoninergic neurons 
originating from the rostral-dorsal and medial raphe terminate in the cortical, 
limbic (hippocampus), midbrain (ventral tegmental area VTA) and hindbrain 
(cerebellum) regions. Neurons originating from the caudal raphe are descending 
and innervate the spinal cord (Fig. 4). Indeed Gershone and Tack (2007) reported 
that “virtually all brain cells are close to at least one serotoninergic fiber”. 
Dysregulation of the serotoninergic system was implicated mainly in the 
pathogenesis of neuropsychiatric disorders (Roth et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Central serotoninergic efferent 
fibers originate from the raphe nucleus to 
innervate several brain structures. Serotonin 
is a neurotransmitter produced in neurons 
originating in the raphe nuclei located in the 
midline of the brainstem. The most caudal 
raphe innervates the spinal cord, while the more 
rostral raphe, the dorsal raphe nucleus and the 
medial raphe nucleus, innervate the rest of the 
central nervous system by diffused projections 
(Dalley and Roiser, 2012). 
CHAPTER I: INTRODUCTION 
 
26 
 
After synthesis in the RN, 5-HT is packed into synaptic vesicles till its release into 
the synaptic cleft upon stimulatory signals. Extracellular levels of serotonin are 
regulated by presynaptic 5-HT reuptake transporter (5-HTT or SERT) and 
degraded by the monoamine oxidase enzymes (MAO) (Fig. 5). Serotonin 
transporter SERT belongs to the family of monoamine transporters together with 
noradrenaline transporter (NET) and dopamine transporter (DAT) (Scholze et al., 
2008). More insights in the function of 5-HT and its mechanism of action emerged 
with the cloning of at least 15 receptor subtypes. 5-HT receptors are grouped in 6 
classes of G-protein coupled receptors (GPCRs) named 5-HT1,2,4,5,6,7 and one class 
of ligand-gated ion channel 5-HT3 (Fig. 5) (Kroeze et al., 2002). The expression of 
5-HT receptors has been described in the mammalian brain including human. 
Receptors autoradiography revealed a region specific distribution of different 
receptors as shown in Fig. 6. Serotonin receptors 5-HT1A, 2A, 2C, 3, 6 and 7 and auto-
receptors 5-HT1B/2B were found in the hippocampus (Brichta et al., 2013). Since 5-
HT receptors and SERT modulate virtually all brain functions, they became the 
major focus of CNS drug development, and many current medications modulate 
serotonin neurotransmission.  
2. Serotonin and mood regulation 
To study the impact of early and adult life serotonin dysregulations in the brain, 
scientists relied on genetically modified animal models. Mice lacking SERT 
(SERT-/-) and MAO (MAO-/-) have constant overexposure to serotonin during early 
development and adult life. Anatomical studies on these mice showed that they 
have failed segregation and barrel structure formation of the thalamo-cortical 
axons. Altered anatomical structure and inhibited cortical neurons migration are 
under the CTRL of 5-HT1B and 5-HT6 receptors (Cases et al., 1996; Salichon et al., 
2001; Meffre et al., 2012). In contrast, mice models lacking TPH2 (TPH2-/-) were 
depleted for 5-HT in the brain during embryonic and adult life. These mice did not 
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show any anatomical abnormalities in the serotoninergic neurons formation 
(Gutknecht et al., 2012). In fact the lack of 5-HT during early life is thought to be 
compensated by 5-HT secreted by the placenta (Gutknecht et al., 2008, Dayer, 
2014). In contrast several studies showed that TPH2-/- mice have juvenile and adult 
fear/aggressive behavior in all experimental paradigms, lack of social interaction 
and severe maternal neglect to pups (Lerch-Haner et al., 2008, Lesch et al., 2012). 
The indoleamine hypothesis stated that the vulnerability to either depression or 
mania was related to the decrease of serotonergic activity. It is attributed to either 
less serotonin release or to fewer serotonin receptors or impaired serotonin 
receptor-mediated signal transduction (Mann, 1999). Later studies reported more 
complication and proved that indeed serotonin dysregulation is associated with 
impulsive aggression, anxiety, cognitive dysfunction and eating disorders 
(reviewed in Dayer, 2014). For example, researchers subjected female mice to 
chronic unpredictable stress and scored their male offspring in forced swim test and 
glucose consumption to assess their depressive-like behavior and in open field and 
exploratory paradigms to assess their aversive reactions to environment. The 
offspring showed depressive- and anxiety-like behavior, aggressiveness and 
anhedonia (Franklin et al., 2010). Studies on human confirmed that maternal 
depression could cause cognitive disabilities such as delayed maturation of 
language discrimination in infants. Within the same study scientists showed that 
infants from mothers treated with SERT inhibitors antidepressants exhibited more 
mature language discrimination abilities compared to infants from untreated 
mothers (Weikum et al., 2012). 
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Functional magnetic resonance imaging (FMRI) studies showed that depression 
induced by chronic mild stress exposure, reduced the connectivity between the RN 
and the hippocampus, hence serotonin dependent-functions in the hippocampus 
was reduced (Gordon and Goelman, 2016). DL-P-Chlorophenylalanine (PCPA), an 
irreversible inhibitor of TPH2, induces acute 5-HT depletion. Two studies used 
PCPA and showed that 5-HT depletion in human brain induced depression and 
cognitive function deficits and more specifically memory impairments. Depressed 
patients that received PCPA treatment had a transient return of depressed 
Figure 5. Serotonin Neuron 
Synapse. Serotonin (5-HT) is 
produced from tryptophan by 
the tryptophan hydroxylase 
(TPH) and packaged into 
storage vesicles until its release 
into the synapse. Multiple 
postsynaptic 5-HT receptors 
mediate 5-HT signaling. 
Serotonin receptors are 7 
subfamilies grouped in 2 types 
as: Ligand-gated ion channel 
(LGIC) and G-protein coupled 
receptors (GPCR). 5-HT levels 
in the synaptic cleft are 
regulated by SERT or degraded 
to inactive metabolites by 
monoamine oxidases (MAO).  
Presynaptic 5-HT1A and 5-HT1B auto-receptors detect the presence of 5-HT in the synapse and 
shut down (-) further 5-HT release. Dopamine receptors D2 and α1-α2- adrenergic receptors 
positively (+) influence 5-HT transmission. (Modified from Saltiel and Silvershein, 2015). 
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symptoms even after treatment with SERT inhibitors antidepressants (Delgado et 
al. 1990, Shopsin et al. 1976). Therefore antidepressants therapeutic effect required 
the enhancement of serotoninergic activity.  
Taking into account that 5-HT receptors and SERT are distributed diversely in the 
brain, several studies dissected their role in deleterious effects of stress, onset of 
depression and response to antidepressants. For instance, partial reduction of SERT 
expression using silencing RNA (SERT-siRNA), increased the level of 5-HT in the 
synapse followed by a reduced expression of 5-HT1A autoreceptor. Silencing SERT 
in mice brains caused decreased immobility in the tail suspension test that is used 
to evaluate antidepressant-like activity (Ferrés-Coy et al., 2013).  Presynaptic and 
postsynaptic 5-HT1A receptors are described as the major mediators of 
antidepressant activity. For example, 5-HT1A autoreceptor agonists inhibited the 
feedback loop that usually leads to 5-HT reuptake from the synapse. Thus the 
increased availability of 5-HT in the synaptic cleft induced an anxiolytic and 
Figure 6. Serotonin receptors distribution in mammal’s brain. (Brichta et al., 
2013) 
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antidepressant effect (Baldwin and Rudge, 1995). Moreover 5-HT by binding the 
postsynaptic 5-HT1A reduced the firing in the post-synaptic neurons inducing and 
anxiolytic effect (Chilmonczyk et al., 2015). Receptors binding studies as well as 
autoradiography studies showed that depressed patients have an increased 5-HT2A 
binding and activity (Ferrier et al. 1986; McKeith et al. 1987).  
3. Serotonin and plasticity: emphasis on adult neurogenesis 
As highlighted previously, 5-HT is an essential neurotransmitter that promotes 
neuronal development during embryonic as well as adult life. Particularly the 
medial raphe provides substantial inputs to various interneurons throughout the 
entire hippocampus and in the hilus (Fig. 7). While the dorsal raphe projections 
terminate preferentially in the SGZ region of the DG, with small axonal 
terminations that appear to be positioned for diffused release of 5-HT (Djavadian, 
2004). The dorsal projections are positioned the best to modulate directly adult 
hippocampal neurogenesis, however also medial projections could modulate the 
neurogenic process through indirect effect on interneurons and network activity 
(Fig. 7) (Gordon and Goelman, 2016). The ablation of the RN (by 5,7-
dihydroxytryptamine injection in the medial/dorsal raphe) or PCPA treatment 
depleted 5-HT levels in the brain, including the hippocampus. This depletion 
caused a drastic reduction of BrdU+ and PSA-NCAM+ cells in the DG (Brezun et 
al., 2000). A RN graft restored the levels of 5-HT, the number of proliferative 
ahNPCs and newly generated neurons (neuroblasts) (Brezun and Daszuta, 2000).  
Interestingly, TPH2-/- mice do not show a drastic reduction in the number of 
proliferative cells, but a severe deficient transition from type 1 stem cells to type 2 
progenitor cells and increased cell death rate. Moreover, DG neurogenesis in 
TPH2-/- mice did not increase after voluntary wheel running, a well-known positive 
modulator of neurogenesis (Klempin et al., 2013). 
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Several studies investigated the different contribution of 5-HT receptors in the 
synaptic plasticity and neurogenesis specifically in the hippocampus. For example, 
5-HT1A is involved in dendrites and spine formation in the hippocampus. 5-HT1A 
antagonist decreased the number of dendritic spines of granule neurons and the 
total dendritic length of DG. This deleterious effect could be reversed by 
administrating 5-HT1A agonist (Yan et al., 1997). Interestingly 5-HT1A is expressed 
in type 1 (NSC) and type 2 (NPC) in the SGZ (Fig. 7). Blocking postsynaptic 5-
HT1A in vivo by a selective antagonist caused a 30% reduction of BrdU
+ in the SGZ 
of treated vs. not treated rats (Radley and Jacobs 2002). Depleting 5-HT secretion 
by PCPA followed by treatment with postsynaptic 5-HT1A agonist (8-OH-DPAT) 
Figure 7.  Illustration of serotonin mode of action during adult hippocampal neurogenesis. 
Serotonergic neurons located in the brainstem raphe nuclei synthesize TPH2 to be released in the 
synaptic cleft. Tracts of serotonergic fibers terminate in the hippocampus projecting into the 
molecular layer (ML) and the hilus, where they make synapses with principle neurons (Blue) and 
interneurons (in orange). Interneurons in the hilus in turn contact immature and newly generated 
granule cells in the SGZ and GCL. Several 5-HT receptors are expressed by the cell populations of 
the DG. 5-HT1AR in type-1 to type-2b ahNPC in the SGZ; 5-HT2B and 2C receptors in adult granule 
cells of the GCL and 5-HT2A in the hilus (modified from Brichta et al., 2013). 
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rescued the number of proliferative ahNPC BrdU+ in the SGZ (Banasr et al, 2003). 
Hippocampal NPC grown in vitro in proliferation expressed TPH2 and produced 5-
HT in the medium. 5-HT1A antagonist and PCPA treatment counteracted the 
proliferation of ahNPC in vitro as well as in vivo. Proliferation was rescued by 
administrating exogenous 5-HT or 5-HT1A agonist (Benninghoff et al., 2010). 
Moreover, 5-HT1A KO mice, even though they do not have lower baseline 
neurogenesis, were not responsive to 5-HT1A agonist (Santarelli et al., 2003). 
Therefore, genetic animal model further confirmed that 5-HT1A is usually required 
for positive modulation of neurogenesis. 
Serotonin receptors 5-HT2 are also expressed in the hippocampus. In details 5-
HT2A expression is very dense in the hilus neurons and interneurons, while 5-HT2C 
mostly marked the granular layer cells. Type 2 NPC in the SGZ expressed 5-
HT2B/2C (Fig. 7) (Alenina and Klempin, 2015). Stimulation of 5-HT2C in vivo 
decreased mRNA and protein levels of BDNF, known to increase adult 
neurogenesis; vice versa blocking 5-HT2C restored the levels of BDNF and 
increased the number of proliferative cells (BrdU+) in the SGZ (Vaidya et al., 1997; 
Klempin et al. 2010). Another group also investigated the implication of 5-HT2 in 
the regulation of ahNPC proliferation and neuronal differentiation in the SGZ. 
Adult rats were treated with DOI (5-HT2A/2C agonist) or ketanserine (5-HT2A/2C 
antagonist). DOI did not change the percentage of proliferative cells, but 
ketanserine produced a decrease in the number of BrdU-labeled cells (Banasr et al, 
2003). In addition to the highlighted role of 5-HT1A and 5-HT2C, also 5-HT4 could 
play a role in adult hippocampal neurogenesis. For example chronic treatment with 
RS6733, a 5-HT4 agonist, increased the number of newborn DCX
+ cells, and more 
specifically the ones with a more mature profile determined by more developed 
dendrites (Mendez-David et al., 2014). Altogether these studies showed that despite 
the opposite role of 5-HT receptors in neurogenesis, serotonin remains necessary 
for the response to positive modulators of neurogenesis such as exercise and 
antidepressants (Klempin et al., 2013). 
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3. Mood disorders: focus on Major Depressive 
Disorder  
Mood disorders are complex pathologies of the brain where the mood spectrum 
involves both depressed and manic episodes. Unipolar, bipolar and major 
depression disorders (MDD) are the most complex and prevalent mood disorders. 
Major depressive disorder is the second leading cause of disability in patients aged 
between 15-44 years. In addition to being ranked as the second in global disease 
burden, MDD is also projected to be the leading cause worldwide by 2030 (World 
Health Organization, 2012; Manji et al., 2001). Despite the discovery of first and 
second generation medications for MDD, at least 50% of patients who begin 
therapy with newer-generation of medications either fail to respond or discontinue 
therapy due to intolerable side effects. Thus, there remains an ongoing need for 
antidepressants that are more effective and/or better tolerated (Berton and Nestler, 
2006; Hunot et al., 2007). 
1. Definition and pathophysiology of MDD 
MDD is a pathology characterized by multiple functional and structural 
impairments in the CNS and behavior. The most commonly listed characteristics 
are: 
1. Emotional/motivational symptoms such as sadness, hopelessness, misery, 
anhedonia (loss of interest and joy), guilt and suicidal thoughts. 
2. Cognitive symptoms such as negative cognition of self and the world 
(worthlessness).  
3. Decreased mental productivity such as memory loss and learning 
disabilities. 
4. Somatic symptoms such as loss of appetite, lack of energy, sleep difficulties 
and weight loss. Under stress the hippocampus and the hypothalamic-
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pituitary-adrenal axis (HPA) are activated and stress hormones such as 
corticosteroids are released by adrenal glands. Stress hormones are the main 
inducers to the somatic symptoms of depression (Eisch and Petrick 2012). 
 
To make an MDD diagnosis, clinicians rely on 3 obligatory symptoms: deep 
sadness, loss of interest and loss of energy that last at least two weeks in the first 
episode (Mill and Petronis 2007). Among others, one animal model of depression 
stood out as the most reliable and closes to human MDD. This animal model 
helped to study the physiological basis of depression. Chronic mild stress (CMS) 
procedure was developed in 1980s and used to induce depressive-like behavior in 
rodents. It is considered reliable since the conditions are realistic, reversible 
(specifically by antidepressant treatment) and the time course is suitable for chronic 
drug treatments (Willner, 2005). CMS could be induced by several factors such as: 
early maternal isolation, adult social isolation, and restraint/immobilization 
episodes. Depressive-like behavior could be assessed by behavioral tests such as: 
the forced swim test (FST), tail suspension test (TST) and hedonic reactivity. In 
fact animals with depressed-like behavior have longer immobility times in the FST, 
TST and have decreased palatable (sucrose) food intake (anhedonia) compared to 
naïve animals. These parameters are indications for helplessness and loss of 
interest. Additionally, MWM test is commonly used to assess the hippocampal-
dependent spatial memory that is impaired by stress (Ehninger and Kempermann, 
2005). Moreover, the advantage of this model is to predict in vivo the mechanisms 
of action of known or putative antidepressants and their effect on depressive 
symptoms and adult neurogenesis (Willner, 2005; Mirescu and Gould, 2006).  
The complex pathophysiology of MDD involves many combined factors such as 
genetic susceptibility, anatomical and morphological alterations and neurochemical 
unbalance.  
Genetic susceptibility. Studies on twins of families with mood disorder history 
showed a heritability of 50% and a significantly higher risk to develop mood 
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disorder during their life. Additionally genetic studies showed that a number of 
chromosomal abnormalities were associated with the development of MDD. Most 
of the genes were linked to neurotransmitters or neurotrophic systems such as: 5-
HT2A receptor, SERT, TPH2 and BDNF (Marchand et al., 2005; Fakhoury, 2015). 
Genetic factors increased the risk of developing MDD when combined with 
environmental factors such as stress and traumatic experience. For example, a 
study showed that patients holding two short (S) alleles instead of 1 or 2 long (L) 
alleles of SERT locus were more sensitive to stressful life events, exhibited more 
severe depressive symptoms and higher number of depressive episodes (Kendler et 
al., 2005).  
Anatomical changes. MDD is accompanied or could cause impaired connectivity 
among neuroanatomical structures involved in the regulation of mood and stress 
response. For example, physical connections between the hippocampus, amygdala 
and prefrontal cortex (PFC) are disrupted physically and chemically in patients 
with MDD. Moreover, the PFC and hippocampus have smaller volumes in patients 
with MDD compared to healthy individuals (Bremner et al., 2000, Cole et al., 
2011, McKinnon et al., 2009; Boldrini et al., 2012). Emotional and cognitive 
aspects of depression such as worthlessness, hopelessness, guilt and memory loss 
could be caused by the loss of these connections.  
Morphological changes. Exposure to stress causes atrophy of neurons, reduced 
number of synapses (specifically glutamatergic synapses), loss of neurons and glia 
in the PFC and the hippocampus in human and rodent brain (Fig. 8) (Duman et al., 
2012). Moreover, postmortem studies on brain tissue showed that the number of 
neurons in the GCL of the DG is reduced in patients with untreated MDD, which 
could explain the reduced volume of the hippocampus in these patients (Boldrini et 
al., 2012). 
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Neurotrophic factor downregulation. Neurotrophins are considered key regulators 
of neuroplasticity hence they underlie the compromised plasticity aspects of MDD 
(Fig. 9). In rodents, acute and chronic immobilization stress as well as chronic pain 
stimuli resulted in decreased BDNF mRNA expression in rat hippocampus. This 
study suggested also that probably depression and pain have similar pathways 
(Maletic et al., 2007).  
 
Decreased BDNF is followed by a low CREB activity, reduced arborization and 
spine formation (Fig. 9) (Duman and Monteggia, 2006). Brains of depressed 
patients have a severe reduction in the number of synapses specifically in the PFC 
and hippocampus (Maletic et al., 2007). A postmortem study on human serum 
Figure 8. Stress alters several forms of neuroplasticity including adult neurogenesis. a. Post-
weaning social isolation stress for 8 weeks significantly reduced dendritic spines in the prefrontal 
cortex (PFC) (visualized by Golgi-Cox staining) (Upper panel CTRL vs. Lower panel stressed). b. 
Chronic restraint stress reduced the length and complexity of cortical dendrites (Reconstitution of 
CTRL left panel vs. stressed right panel). c. Chronic unpredictable stress reduced the number of 
proliferative cells in the hippocampal SGZ. Visualized by bromodeoxyudridine BrdU and 
doublecortin (DCX) labeling markers of neuroblasts (CTRL upper panel vs. stressed lower panel). 
(Pittenger and Duman, 2008). 
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showed that BDNF levels are reduced in samples from depressed patients, and 
antidepressant therapy restored brain BDNF levels to the normal range 
simultaneously with improvement in depressive state (Shimizu et al., 2003). Mice 
lacking for BDNF did not show depressive-like symptoms in the FST. The infusion 
of BDNF into the hippocampus and the RN region of depressed wild type mice 
mimicked the effects of antidepressants (Eisch et al., 2003). Similarly, fibroblast 
growth factor (FGF) is downregulated in the hippocampus of patients with MDD. 
Additionally insulin-like GF- I (IGF-I) is increased in the hippocampus by 
antidepressants treatment. IGF-I infusion into the brain has an anti-depressant like 
effect similarly to BDNF (reviewed in Duman et al., 20-16).  
Neurochemical unbalance: emphasis on monoamine deficiency. Back in 1960, 
European and American researchers simultaneously suggested that depression was 
caused by deficiency in the catecholamine norepinephrine (NE) and the 
indoleamine 5-HT in the brain (Fig. 9). In fact NE from the locus coeruleus (LC) 
and 5-HT from the RN are the most dominant innervations in the CNS regions 
involved in MDD (Berton and Nestler, 2006). The involvement of the 
monoaminergic system was initially postulated after the finding that monoamine 
depleting agents such as “reserpine” (anti-hypertension drug) could produce 
depressive symptoms. Animal research studies showed that reserpine depleted 5-
HT and NE from neurons. Simultaneously, patients showed severe depressive state 
and sedative behavior. In contrast monoamine oxidase inhibitors (MAOI) increased 
the levels of monoamines in the synapse and antagonized the effect of reserpine 
(Manji et al., 2001; Lopez-Munoz and Alamo, 2009). Subsequently, 
pharmacological studies showed that 5-HT receptors might add more complication 
to antidepressants effect. Serotonin receptors 5-HT1A, 5-HT2A/2C and 5-HT4 emerge 
as candidates to mediate antidepressant response. For instance, they regulate 
normal development of dendritic spine density, synapse formation of pyramidal 
and granule cells in the DG, long-term plastic changes that decrease anxiety-like 
behavior and mediate ahNPC maturation at the late phases (Djavadian, 2004). For 
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example, 5-HT1A is overexpressed in the hippocampus of MDD patients. This 
compensatory mechanism is a response to decreased levels of 5-HT (Santarelli et 
al., 2003). In contrast, increased binding on 5-HT2A/2C receptors is responsible for 
adverse side effects related mainly to weight changes and sleep deprivation (De 
Vry and Schreiber, 2000). Activated 5-HT4 increases the levels of BDNF and 
ahNPC proliferation in the DG through cAMP signaling cascade (Djavadian, 2004; 
Mattson et al., 2004; Ferrés-Coy et al., 2013).  
Similarly to 5-HT, low levels of NE were specifically associated with cognitive 
dysfunction, fatigue and apathy. These associations solicited scientist to study more 
deeply the role of NE in cognitive and psychiatric disorders that will not be 
detailed in the context of this work. Many other neurotransmitters systems were 
found to be involved in MDD but to a less extent compared to 5-HT and NE. For 
example, the synthesis and release of GABA are reduced in response to acute and 
chronic stress whereas the glutamate levels are high after stress. Likewise increased 
levels of histamine in the limbic system have been associated with depression and 
sleeping problems in patients with MDD (reviewed in Marchand et al., 2005). 
2. Antidepressants: classes and mechanisms of action  
During the 1950s, while carrying out trials on a new medication for tuberculosis, 
researchers noticed that the medication had also a mood improving effect on 
tuberculosis patients. Clinicians showed that anti-tuberculosis drug improved the 
depressive state of patients (raised mood, weight gain, better interpersonal capacity, 
increased interest in themselves and surroundings). Scientists showed that 
“iproniazid” had indeed MAO inhibitory activity (thus the name MAOI, Fig. 10 A). 
It increased the levels of 5-HT and NE in the synaptic cleft by inhibiting their 
degradation (Sandler, 1990). MAOI caused severe side effects thus their use 
became limited. 
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At the same year of MAOI discovery in 1957 tricyclic (TC) molecules were 
characterized chemically similar to antihistaminic drugs. Therefore, they were 
tested for their potential antihistaminic and sedative effects. R. Kuhn, a famous 
psychiatrist at that time, showed that they improved the symptoms in patients with 
depressive psychosis and raised the first suggestion of potential antidepressant 
effect. TC molecules started to be used as antidepressants (hence the name TCA, 
Fig. 10 A). TCA such as imipramine showed anti-histaminic activity as well as NE 
and 5-HT reuptake inhibition (NRI and SRI). TCA had low MAOI activity 
therefore they had safer profile in patients (Lopez-Munoz and Alamo, 2009). In 
Figure 9. Synaptic connectivity and chemical balance is lost in stressed brain. A. Normal 
state: healthy hippocampal pyramidal neurons receive physiological levels of monoamines (5-
HT, NE), glutamate and BDNF (Thick arrows). B. Severe stress increases the levels of 
glucocorticoids that, in turn inhibit CREB signaling causing reduction of BDNF, monoamines 
and stimulatory glutamate thus inducing radical loss of dendritic arborizations and spines (Thin 
arrows). C. Antidepressants, by activating CREB signaling or by increasing monoamines restore 
BDNF levels, dendritic arborizations and spine number. (Modified from E. Nestler et al., 2002) 
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summary, the first-generation of antidepressants was effective because it enhanced 
serotonergic or noradrenergic mechanisms or both. Unfortunately, even TCA were 
still non-selective drugs with considerable side effects due to: anti-histaminic 
activity (sedation, sleep), cholinergic activity (tremors), anti-muscarinic M1 
(constipation, dry mouth, urinary retention) and α1-adrenergic receptor sites 
(orthostatic hypotension, sexual dysfunction) (Duman et al., 2016). Moreover, 
TCA and MAOI had a fast chemical effect on the amine levels in the synaptic cleft, 
but the therapeutic effects did not take place before 4 weeks of treatment (Pittenger 
and Duman, 2008). It is important to point out that these initial drugs were 
approved and prescribed merely upon clinical observation without real knowledge 
of the mechanism of action. Since then, rational drug design (relying on the 
knowledge of the biological target and its role) led to the introduction of selective, 
faster, and better tolerated antidepressants.  
The second generation of antidepressants included: selective serotonin reuptake 
inhibitors (SSRI), serotonin and norepinephrine reuptake inhibitors (SNRIs) and 
noradrenaline reuptake inhibitors (NARI) (Fig. 10 B). Selective SSRI had similar 
efficacy as TCA but lacked the anti-muscarinic activity, thus they had less 
cardiovascular side effects. Their major side effects were headaches, sexual 
dysfunction, and weight gain due to 5-HT2C agonistic activity. SNRI were more 
balanced on both receptors system, had the same efficacy as TCA and SSRI yet 
they lacked the muscarinic activity and α1 AR blockade, thus their major side 
effect was hypertension. NARI had mainly analgesic activity but they dangerously 
increase the arterial blood pressure, hence they were subjected to prescription 
restrictions (Berton and Nestler, 2006).  
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As part of the effort to address the unmet need of better tolerated antidepressants, 
attention has been given to multimodal acting drugs and new mechanisms of action 
for depression treatment. Multifunctional or multimodal drugs could be used in 
multiple disorders and have less severe side effects controlled by dosage 
regulations. As an example (i) serotonin antagonist and reuptake inhibitors (SARI) 
(Fig. 10, B) such as trazodone and nefazodone that have the same efficacy as TCA 
and SSRI with additional anxiolytic and hypnotic activity (Lopez-Munoz and 
Alamo, 2009); (ii) agomelatine that is melatonergic receptor agonist and 5-HT2C 
receptor antagonist (Soumier et al., 2009); (iii) vortioxetine that is a 5-HT3,7,1D 
antagonist, 5-HT1B partial agonist, 5-HT1A agonist and SERT inhibitor (Guilloux et 
al., 2013). Several studies are focusing on understanding how multimodal drugs 
induce their antidepressant effect, their off-label therapeutic use and their side 
effects.  
Figure 10.  Antidepressant Mechanism of action. A. Monoamine oxidase inhibitors (MAOI) 
inhibit mitochondrial oxidation of monoamines in the presynaptic neuron. Tricyclic 
antidepressants (TCA) inhibit 5-HT transporter (SERT) and/or noradrenaline transporter (NET) 
B. Serotonin Antagonist and Reuptake Inhibitors (SARI) antagonize serotonin receptor 2 (5-HT2) 
and block SERT; Selective serotonin reuptake inhibitors (SSRI) block serotonin reuptake 
transporter (SERT) on the presynaptic neuron; Serotonin and Noradrenaline Reuptake Inhibitors 
(SNRI) block SERT and NET. All mechanisms increase the level of 5-HT and NE in the synaptic 
cleft. (Modified from Brigitte Schiott, Biomodeling, Semper Ardens Research project, 2016) 
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3. Adult hippocampal neurogenesis, MDD and antidepressants  
Environmental interventions such as learning tasks, enriched environment and 
physical activity stimulate adult neurogenesis and have an antidepressant-like 
effect on behavior (Sahay and Hen, 2007). By the same token scientists suggested 
that antidepressants might also increase adult hippocampal neurogenesis. “The 
neurogenic hypothesis of depression” postulated that decreased production of new 
granule cells in the dentate gyrus of the hippocampus is linked to the 
pathophysiology of depression and that the increase in hippocampal neurogenesis 
and plasticity are required for the behavioral effect of antidepressant treatment 
(Eisch and Petrick, 2012).  
The ablation of the SGZ by X-ray irradiation inhibited the onset of behavioral 
improvement mediated by fluoxetine (SSRI) on non-human primate animal model 
of MDD (Perera et al., 2011). Boldrini and colleagues showed that the number of 
ahNPC in the hippocampal SGZ of patients with MDD is increased in SSRI 
antidepressant-treated versus non-treated patients (Boldrini et al., 2009). Fluoxetine 
accelerated synaptogenesis (increase spines formation) and enhanced LTP in the 
hippocampal neurogenic niche. These improvements were accompanied with 
improved depressive behavior (Wang et al., 2008). Moreover, several studies 
showed that chronic (14 days or more) treatment with fluoxetine upregulates NPC 
proliferation rate (increase the number of BrdU+ cells in the SGZ) and immature 
neuron survival rate (Malberg et al, 2000; Kodama et al, 2004; Huang and Herbert, 
2006; Marcussen et al, 2008). Similar results have been seen in experiments using 
citalopram and escitalopram (SSRI). In details, scientists induced a depressive state 
by olfactory ablation in rats. Rats were treated with citalopram in short and long 
term paradigms to assess the proliferation and survival of newly generated neuron. 
They showed that citalopram increases the number of proliferative BrdU+ cells and 
restore the number of PSA-NCAM+ surviving new neurons to levels compared to 
control rats (Jaako-Movits et al, 2006). Another study used CMS paradigm and 
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assessed the effect of escitalopram on ahNPC proliferation and differentiation. 
They showed that, similarly to fluoxetine and citalopram, also long term treatment 
with escitalopram increased the neurogenesis in the SGZ with simultaneous 
increase in glucose consumption (hedonic behavior) as a sign of alleviated 
depressive state (Jayatissa et al, 2006). Citalopram and reboxetine (NARI) may 
potentially upregulate neurogenesis through BDNF signaling since serum and 
hippocampal regions BDNF levels are increased following treatment (Russo-
Neustadt et al, 2004). Several studies used chronic treatments with antidepressants 
such as SSRI, TCA, NRI and MAOI to enhance several steps of the neurogenic 
process in the DG of rodents and non-human primates. Notably, the increase of 
neurogenesis was simultaneous to the onset of therapeutic effect of antidepressants 
(Malberg et al., 2000, Santarelli et al., 2003, Airan et al., 2007). Neurotrophic 
factors such as BDNF and IGF-1 activate ERK in neurons to induce 
neuroprotection and in ahNPC to increase proliferation and differentiation 
(Yamada et al. 2001; Shelton et al. 2004). Similarly, mood stabilizers such as 
lithium and valproate activate ERK and enhance both proliferation and survival of 
ahNPC in the SGZ (Hao et al, 2004; Hanson et al, 2011a). Low serum levels of 
BDNF were associated with depression in patients. Treatment with antidepressant 
and, specifically, with SSRI was associated to normalized levels of BDNF 
(Molendijk et al., 2011). Agomelatine that is a multimodal antidepressant also 
increased the survival of ahNPC via melatonergic receptor agonistic and 5-HT2C 
antagonistic activities accompanied with increased BNDF signaling (Soumier et al., 
2009). Similarly, acute and repeated dosing of vortioxetine (multimodal 
antidepressant) significantly increased the number of BrdU+ cells and DCX+ with 
tertiary dendrites (more mature cells). Vortioxetine increased proliferation, cell 
survival and stimulated maturation of immature granule cells in the hippocampal 
SGZ (Guilloux et al., 2013). 
Our group also participated in consolidating the neurogenic hypothesis of 
depression and the role of antidepressants. Pregabalin (PGB) and gabapentin (GBP) 
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are clinically relevant anticonvulsant, analgesic and anxiolytic drug. Interestingly, 
PGB and GBP are also prescribed to MDD patients with post-traumatic stress and 
anxiety (Stein et al., 2008). Our group showed that PGB and GBP increase, in a 
concentration-dependent manner, the number of mature and immature neurons 
generated from the in vitro model of ahNPC. They act through α2-δ1 subunit of the 
voltage-gated calcium channels expressed by hippocampal NPC (Valente et al., 
2012). More interestingly, this effect was blunted by inhibiting the nuclear 
translocation of NF-κB p50/p65 subunits to the nucleus (Valente et al., 2012). 
Within the same study PGB interestingly decreased depressive-like behavior in 
mice that received unpredictable CMS, since it reduced immobility time in both 
TST and FST. Thus the antidepressant activity of PGB and GBP could be 
potentially mediated by neurogenesis (Valente et al., 2012). In another study, our 
group focused on Acetyl-L-carnitine (ALC) that can (i) cross the blood brain 
barrier, (ii) improve mood disorders in human particularly in elderly and (iii) have 
an analgesic effect in rodent studies (Zanardi et al., 2006; Cuccurazzu et al., 2013; 
Bortolotto et al., 2014). ALC is an acetyl group donor to proteins including NF-𝜅B 
p65 subunit (Chiechio et al., 2006), but it was not known how ALC can have an 
antidepressant effect. Our group hypothesized that the antidepressant activity of 
ALC could be due to a proneurogenic effect mediated by NF-𝜅B signaling 
pathway. ALC showed a potent pro-neurogenic activity on ahNPC in vitro. This 
effect was mediated by the activation of NF-𝜅B pathway and subsequent 
upregulation of metabotropic glutamate receptors 2 (mGlu2) expression in vitro 
and in vivo. These cellular mechanisms were inhibited by blocking p65 
translocation to the nucleus. In vivo ALC reversed depressive-like behavior in 
mouse model of MDD (Cuccurazzu et al., 2013). The antidepressant activity 
described by our group was also confirmed by another study on genetic rat model 
of depression. Moreover they compared ALC to TCA and showed that rats had 
reduced immobility in FST and increased palatable food consumption. More 
interestingly in their model the onset of ALC effect required three days of 
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treatment while TCA required 14 days of treatment (Nasca et al., 2013). Altogether 
our group and literature studies suggested that increasing neurogenesis might be a 
new mechanism of action for antidepressants. It is still not known if multimodal 
antidepressants such as trazodone (SARI) could have an effect on neurogenesis and 
by which mechanisms.  
4. Trazodone  
Trazodone hydrochloride (TZD) is a dose dependent multifunctional drug that has 
advantages over other antidepressants in terms of therapeutic use. It is prescribed as 
antidepressant at high doses and has multiple off-label uses mainly for sleep and 
anxiety disorders at low doses. TZD detailed mechanism of action and diverse 
therapeutic benefits are still not fully characterized.  
1. Trazodone: peculiar mechanism of action 
Trazodone hydrochloride is a phenylpiperazine-triazolopyridine compound first 
discovered by Angelini research laboratories in Italy in the 1960s. Trazodone, 
similarly to SSRI and their derivatives, was introduced as the second generation of 
antidepressants after TCA and MAOI. Trazodone had comparable efficacy to TCA 
and SSRI antidepressants and yet was more tolerated. Early studies in rat brain 
showed that given acutely or chronically with doses similar to other SSRI 
antidepressants, trazodone appeared inactive as an inhibitor of serotonin reuptake 
by SERT but showed 5-HT2A/C antagonistic activity (Fuller et al., 1984). Affinity 
binding studies showed that Trazodone has 50 to 100 fold higher affinity to 5-
HT2A/C than SERT (Fig. 12 A). To elicit a therapeutic effect trazodone is 
administrated at a dose that recruits both the weaker binding to SERT and the 
strong binding 5-HT2A/C receptor (Fig. 11, B) (Knight et al., 2004; Stahl et al., 
2009). Together these properties annotated trazodone as a dose-dependent 5-HT2A/C 
antagonist and serotonin reuptake inhibitor (SARI). Based on the knowledge of 
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both mechanisms of action outcome, trazodone mechanisms are suggested to act 
synergistically (Stahl et al., 2009). On one hand antagonizing 5-HT2A/C, trazodone 
similarly to TCA antidepressants, increase the release of dopamine in the cortex 
inducing antidepressant activity (Chagraoui et al., 2015). 
 
 
 
 
 
 
 
 
 
 
 
 
On the other hand, by blocking SERT, trazodone increases the availability of 
serotonin in the synapse and allows the activation of 5-HT1A resulting in 
hyperpolarization and reduced neuronal excitability and firing (Chilmonczyk et al., 
2015). The hyperpolarization makes the neurons less excitable and leads to 
antidepressant and anxiolytic activity. Additionally, trazodone has different binding 
affinities to various receptors such as α1 and α2 adrenergic receptors, histamine 
Figure 11.  Chemical structure of trazodone and its antidepressant mechanism. A. Chemical 
structure of phenylpiperazine-triazolopyridine, trazodone B. Schematic representation of 
trazodone mechanism of action. Trazodone is a serotonin antagonist and reuptake inhibitor 
(SARI). It inhibits serotonin reuptake by blocking SERT on the presynaptic membrane allowing 
serotonin to activate it 5-HT1A receptor and antagonizes 5-HT2A receptor. (Stahl, Trends in 
Psychopharmacology, 2009) 
A B 
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receptor 1 (H1), dopamine receptor 2 (D2) and muscarinic receptor (M1) (Fig. 12 
A). Trazodone acts as agonist or antagonist with different binding affinities (Fig. 
12 B). Electrophysiological studies in the dorsal raphe and hippocampus of rats 
showed that administration of trazodone sustain serotonin availability not only by 
blocking SERT but also by desensitizing the 5-HT1A/1B presynaptic auto-receptors. 
The desensitization of 5-HT auto-receptors induced a tonic release of serotonin in 
the synapse resulting in a sustained firing rate of 5-HT neurons (Ghanbari et al., 
2010).  
Multifunctional activity of trazodone has a high pharmacological relevance with 
regards to side effects and off-label uses. 5-HT2A/C receptors activation is known to 
induce antidepressants side effects such as insomnia, sexual dysfunction and 
anxiety. Trazodone antagonistic activity on 5-HT2A/C alleviates anxiety and sexual 
dysfunction and induce hypnosis (Stahl et al., 2009). Arousal mechanisms are 
known to involve the activation of several neurotransmitter systems such as 
serotonin, norepinephrine, dopamine, acetylcholine, and histamine. By 
antagonizing all these systems simultaneously trazodone impairs arousal and 
induces sleep. Thus low doses act as hypnotic drug to improve sleep disorders 
related and not related to MDD.  
Trazodone is absorbed rapidly with peak in plasma attained after 1-2 hours 
following an immediate release (IR) tablet. It is metabolized by cytochrome P450 
(CYP450) isoforms that generate different metabolites including active ones such 
as meta-chlorophenylpiprazine (m-CPP). Trazodone metabolite m-CPP inhibits 
SERT, antagonizes 5-HT2A and act as partial agonist of 5-HT1A and 5-HT2C. The 
levels of m-CPP (0.056 μg/ml) are only 10% of TZD levels (0.62 μg/ml) in the 
plasma of treated patients (Mittur, 2011). Some researchers claim that such low 
levels of m-CPP are negligible. Thus, antagonist activity of trazodone overwhelms 
m-CPP activity that does not influence trazodone’s clinical outcomes (Stahl et al., 
2009). 
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2. Therapeutic doses, efficacy and side effects 
Trazodone is marketed as an antidepressant approved by U.S. Food and Drug 
Administration (FDA) in 1982. Today, it is sold under different brands names such 
as Desyrel®, OleptroTM, Deprax and others. Generic formulation is also available 
and is manufactured by several pharmaceutical firms. Trazodone hydrochloride is 
available in different formulations such as IR tablets, prolonged release tablets 
(TzCOAD), oral drops and injectable solution. Therapy with IR tablets must be 
gradual starting with low doses 75-150 mg/day, and reaching 300 mg/day. In the 
elderly, it is given at lower doses of maximum 100 mg/day (Fagiolini et al., 2012). 
Figure 12. Trazodone binds different receptors and 
transporters populations A. Graph representing 
trazodone binding affinity to different receptor 
population relatively to the strongest binding on 5-
HT2A. B. Affinity of trazodone for various human 
pharmacological targets. (Modified from stahl et al., 
2009). 
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The novel TzCOAD prolonged release (once a day tablets) was developed in 2010 
and approved recently by FDA and many European countries.  
Trazodone efficacy was compared to TCA (amitriptyline and imipramine), SSRIs 
(fluoxetine, paroxetine, sertraline, citalopram and escitalopram), SNRIs 
(venlafaxine and mirtazapine) and noradrenaline/dopamine reuptake inhibitors 
(bupropion).  The Hamilton rating Scale for Depression (HAM-D) and Geriatric 
Depression Scale (GDS) scores showed that trazodone has the same efficacy as 
other antidepressants (reviewed by Fagiolini et al., 2012). Additionally, to its 
efficacy, it had advantages for patients with major depression who have sleeping 
difficulties or show prevalent sleep disturbance. The great improvement of sleep 
was measured by a HAM-D-related sleep disturbance score. Trazodone was 
efficacious in treating insomnia and anxiety associated to MDD. Patients diagnosed 
with MDD under trazodone treatment showed improved insomnia, depression and 
anxiety symptoms (Saletu-Zyhlarz et al., 2003). It is frequently prescribed as a 
concomitant agent along with an SSRI/SNRI or as monotherapy.  
Trazodone is a well-tolerated drug with side effects similar to SSRI including 
drowsiness (sedation and somnolence), hypotension, headache, dizziness and dry 
mouth. Drowsiness is the major side effect that accompanies the peak concentration 
of trazodone in the plasma. Elderly patients are more likely to experience the 
sedative or hypotensive effects of trazodone than young adults. By avoiding this 
peak mainly related to IR tablets may reduce the severity of the side effects (Mittur, 
2011). Therefore by developing TzCOAD prolonged release tablets, patients were 
able to describe small differences in side effects severity compared to IR tablets. 
Namely, patients that were treated with TzCOAD reported less severe dizziness, 
drowsiness, dry mouth, headaches and nausea (Moon et al., 2008). Dry mouth has 
been reported in approximately 15–30% of patients during trazodone therapy and 
probably results from α-adrenergic blockade. Some case studies reported 
spontaneous penile erection and rare priapism. Priapism is also a known effect of 
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m-CPP mediated by its activity at 5-HT1C receptors. Trazodone was not associated 
with malformations in infants when administrated during pregnancy. In summary, 
and importantly, trazodone showed an overall significant lower rate of 
discontinuous treatment related to side effects compared to SSRI antidepressants 
(Anderson et al., 2000).  
3. Trazodone as a neuroprotective antidepressant  
In addition to their therapeutic activities, several antidepressants have also 
displayed important neuroprotective activity. Trazodone has also a potential 
neuroprotective activity specifically important taking into consideration its 
multifunctional properties. First, recent studies on animal models of Huntington 
Disease (HD) revealed that trazodone reduces free radicals and improves 
mitochondrial respiratory complex activity after 2 weeks of treatment in HD rat 
models. Additionally, it improved memory performance and motor activity in HD 
rats (Lauterbach, 2013). These studies need to be extended beyond rat models and 
be assessed in human patients under conventional doses. The mechanism by which 
trazodone improved memory and motor activity in HD rats is still unknown 
(Fagiolini et al., 2012).  
Several studies reported that antidepressant treatments of glial cells had anti-
inflammatory effects. For example in a co-culture model of astroglia-microglia, an 
inflammatory status was induced by increasing the proportion of microglia. 
Treatment with venlafaxine (SNRI) reversed the pro-inflammatory status within the 
model (Vollmar et al., 2008). Likewise, fluoxetine (SSRI) was shown to counteract 
astrocytic cell loss in animal models of depression, and increase astrocyte glucose 
release, that provides essential energy substrates for neurons to sustain normal 
function and cellular integrity (Czéh et al., 2006). Up till a year ago, it was still 
unknown if astrocytes are a target for trazodone or if it has a neuroprotective effect 
in physiological conditions and after an inflammatory insult. Daniele and 
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colleagues were the first to study the potential role of trazodone in neuroprotection 
and neuroinflammation. They treated cultured human astrocytes with trazodone 
before and after an inflammatory challenge, namely by exposure to 
lipopolysaccharide (LPS). TZD treatment of astrocytic culture enhanced mRNA 
expression of growth factors and lactate release from astrocytes. It activated AKT 
signaling pathway while simultaneously decreased pro-inflammatory signaling by 
inhibiting interferon γ (IFN-γ) release, constitutive phosphorylation of ERK1/2 and 
JNK constitutive phosphorylation. These effects were mediated by 5-HT1A 
stimulation, 5-HT2A/C blockade and α1 and α2 AR antagonism. Moreover, after 
LPS/TNF-α insult trazodone reversed the inflammatory status by: (i) normalizing 
astrocyte proliferation specifically through the activation of 5-HT1A and 
antagonism of 5-HT2A/C, (ii) restoring the release of lactate, (iii) inhibiting the 
secretion of inflammatory mediators such as IL-6 and IFN-γ production, (iv) 
counteracting the decrease of neurotrophic factors and (v) counteracting the 
activation of ERK1/2 and JNK (Daniele et al., 2015 a). In another study of the 
same year, the same group was able to show that TZD is neuroprotective not only 
on astrocytes but also on human neuron-like cell. Indeed trazodone also reversed 
the inflammatory status and restored cell viability through the inhibition of 
JNK/p38 pathway (Daniele et al., 2015 b). 
In essence, TZD is a well-tolerated drug with multifunctional properties. It has an 
important relevance in treating depression-related symptoms and insomnia. The 
newly discovered astrocytic and neuronal protective effect of trazodone raises the 
question about additional novel therapeutic actions and their cellular and 
subcellular pathways. For example, it is unknown if trazodone like other 
antidepressants may modulate adult hippocampal neurogenesis.    
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5. NF-𝜅B 
1. NF-𝜅B signaling pathway and subunits in the CNS 
NF-𝜅B proteins are transcription factors ubiquitously expressed in all tissues 
including the brain. They regulate genes involved in immunity, apoptosis, cell 
survival, cellular growth, cellular repair and oncogenesis. The NF-𝜅B family is 
composed by p50, p52, p65 (RelA), c-Rel, and RelB subunits that form 
transcription factors after dimerization. They all share the Rel homology domain 
responsible for DNA binding, dimerization, nuclear translocation and interaction 
with the inhibitor protein 𝜅B (I𝜅B). Non-active proteins are retained in the 
cytoplasm by I𝜅B. There are two activation pathways of NF-𝜅B: the canonical 
pathway relying on the I𝜅B inactivation and an alternative activation pathway 
mediated by NF-𝜅B inducing kinase (NIK). Upon activation, NF-𝜅B members are 
transferred to the nucleus to repress or activate target gene expression (Kaltschmidt 
et al. 1993). NF-𝜅B subunits dimers such as p50/p65 and p50/p50 are expressed in 
the CNS by neuronal and non-neuronal cells (Schmidt-Ullrich et al. 1996). 
Interestingly, I𝜅B-NF-𝜅B dimers complexes were also found in synapses distant 
from the nucleus. Upon glutamatergic stimulation, NF-𝜅B also acted as a signal 
transducer by delivering signals from active synapses to the nucleus (Mikenberg et 
al., 2007). Hence increased synaptic activity induces NF-κB pathway activation 
(Romano et al. 2006). Moreover, constitutive NF-κB activity was described in 
hippocampal neurons in vivo as well as in vitro (Bhakar et al. 2002; Schmidt- 
Ullrich et al. 1996). 
2. NF-𝜅B: relevance to plasticity and adult neurogenesis  
Initially NF-𝜅B family was described to have a role in proliferation, survival, 
differentiation, migration and apoptosis of neurons during development and upon 
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neuronal activity (Bortolotto et al., 2014). Recently, multiple studies showed that 
many synaptic plasticity events regulate the NF-𝜅B subcellular distribution, DNA 
binding activity, and transcription. Indeed NF-κB activation and/or inhibition 
regulate neurite outgrowth, arborization and guidance (Gavalda et al. 2009; Salles 
et al. 2014). Therefore, NF-κB transcription factors have a central role in 
translating synaptic events into gene expression changes that might have a longer 
duration (Kaltschmidt and Kaltschmidt, 2009).  
Our group was among the first to demonstrate that NF-κB family members are 
expressed in the adult active neurogenic zone SVZ and SGZ (Denis-Donini et al., 
2005; Denis-Donini et al., 2008; Meneghini et al., 2010). NF-κB signaling pathway 
is involved in the different steps of the neurogenic process including proliferation, 
survival, differentiation and migration of embryonic and adult newly generated 
neurons (Widera et al. 2008; Denis-Donini et al., 2008; Zhang and Hu 2012). 
Upstream ligands and receptors that activate NF-κB could affect adult 
neurogenesis. One of the first studies showed that VEGF directly promotes adult 
NSC survival and hippocampal-dependent memory via NF-κB downstream 
effectors (Licht et al., 2011). Therefore, growth factors in physiological conditions 
and in injuries are able to increase adult neurogenesis through NF-κB transient 
activation. Our group demonstrated that receptors for advanced glycation end-
products (RAGE) are expressed by hippocampal NSC and NPCs. Upon RAGE 
engagement, the NF-κB canonical pathway is activated and NF-κB dimers are 
translocated to the nucleus. Several RAGE ligands such as alarmin HMGB-1, 
S100β, and AGE-BSA, stimulated both proliferation and neuronal differentiation of 
SVZ-derived NPC in vitro. This effect was blocked by SN-50 that inhibits the 
nuclear translocation of NF-κB subunits (Meneghini et al., 2010). Moreover, mice 
lacking for NF-κB p50 (p50-/-) subunits were developed by David Baltimore in 
1995 to study the role of p50 in the immune system (Sha et al., 1995). Interestingly 
active NF-κB was associated with increased proliferation of nestin+/Sox-2+ NPC 
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and early neuronal differentiation in the SVZ (Zhang et al., 2012). Since our group 
already showed that NF- κB p50 subunit is expressed in the SGZ, this model was a 
huge advantage to study the role of p50 in adult hippocampal neurogenesis. Our 
group was able to show that p50KO mice have a net reduction in the newly 
generated neurons in the hippocampal SGZ (Fig. 13). Reduced ahNG was 
correlated to a selective impairment in hippocampal-dependent short-term spatial 
memory (Denis-Donini et al., 2008).  
 
 
 
 
 
 
 
 
 
Other groups also showed that treatment with SN50 resulted in impaired memory 
consolidation in mice (Lubin et al., 2007). NF-κB downstream target genes such as 
monocyte chemoattractant protein-1 (MCP-1) stimulates the migration of newly 
generated neurons in adult rat SGZ (Widera et al., 2004). Using the same approach 
our group showed that Aβ 1−42 oligomers and HMGB-1, both involved in 
Alzheimer's disease, could promote neuronal differentiation by the activation of 
RAGE/NF-κB axis thus consolidating the role of NF-κB in neurogenesis 
(Meneghini et al., 2013). Other groups also showed the role of NF-κB in synaptic 
Figure 13: Reduction of newborn neurons in NF-κB p50KO mice. A-B Representative 
images of doublecortin (DCX, marker of immature neurons) in the DG of WT (A) and p50KO 
mice (B). C-D Representative images of Calretinin (CR, marker of mature neurons) in WT (C) 
and p50KO mice (D). E. Quantification of total number of DCX+ and CR+ cells in the DG of 
both genotypes. (Denis-Donini et al., 2008) 
DCX 
DCX CR 
CR 
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plasticity and memory. p50KO mice showed decreased LTP (the main 
electrophysiological parameter used to study the formation and consolidation of 
memory formation) and long term memory alterations in MWM test (Overstreet 
and Wegener, 2013). 
Many studies showed that NF-κB signaling pathway contribute to neural plasticity 
(Mattson, 2005) and cognitive tasks (Meffert and Baltimore, 2005). Synaptic 
plasticity and adult neurogenesis are reduced in depression therefore we could 
hypothesize that NF-κB could also be involved in reduced neurogenesis observed 
in MDD. Indeed NF-κB could be the way for certain antidepressants to exert their 
antidepressant activity via increased neurogenesis (Pittenger and Duman, 2008; 
Hanson et al., 2011). Our lab also participated in showing that members of NF-κB 
are important contributors in the SGZ neurogenic response to multiple clinically 
relevant drugs with antidepressant-like activity (Bortolotto et al., 2014; Meneghini 
et al. 2014; Cuccurazzu et al., 2013).  
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Outline of the thesis 
Adult hippocampal neurogenesis (ahNG) is a peculiar form of neural plasticity 
involved in cognition, mood regulation and stress response (Aimone et al., 2010, 
2014; Eisch and Petrik, 2012). The neurogenic niche of the hippocampus, located 
in the subgranular zone (SGZ), is a microenvironment where neural stem cells 
(NSCs) are logged, proliferate and start differentiation (Alvarez-Buylla et al., 2004, 
Quinones-Hinojosa at al., 2006). Within the niche NSCs differentiation could be 
regulated by astrocytes released factors such as neurotransmitters, trophic factors 
and several neuro-modulatory proteins (Newman, 2003; Liauw et al., 2008; Song et 
al., 2002). AhNG is profoundly deregulated in several neurodegenerative and 
neuropsychiatric disorders where also astrocytes had altered phenotype and 
function (Pekny et al., 2016). The mechanisms by which astrocytes control adult 
hippocampal neural progenitor cells (ahNPC) are still poorly understood. The 
discovery and characterization of potential pro-neurogenic or anti-neurogenic 
molecules and their downstream signaling is still an open field of research. In 
previous work our laboratory showed that NF-κB p50 is a crucial signaling for 
ahNPC differentiation (Bortolotto et al., 2014). Indeed NF-κB p50 knockout (KO) 
mice had reduced late neuronal maturation correlated with selective defects in 
hippocampal-dependent short-term memory (Denis-Donini et al., 2008). In vitro, 
ahNPC from wild type (WT) and p50KO mice are not significantly different in 
their neurogenic potential. These observations triggered us to study possible cell-
autonomous and non cell-autonomous defects caused by NF-κB p50 depletion on 
both astrocytes released factors and ahNPC differentiation. In chapter III we 
present a published work where we studied the effect of astrocytes released factors 
in astrocytes conditioned medium on ahNPC differentiation. In this in vitro work, 
we focused on studying the role of NF-𝜅B transcription factors, specifically the 
absence of NF-𝜅B p50 subunit in: (i) WT and p50KO ahNPC differentiation and 
response to medium deriving from WT and p50KO astrocytes, (ii) potential 
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differences between WT and p50KO astrocytes released factors, (iii) the 
neurogenic effect of differentially released factors from WT and p50KO astrocytes 
on ahNPC and (iv) proneurogenic molecules receptors expression in ahNPC. 
Even though NSCs reside in a microenvironment their behavior could be also 
modulated by exogenous factors such as stress (Kempermann, 2002) and 
pharmacological treatment (Aimone et al., 2014). While ahNPC proliferation and 
differentiation is downregulated after acute and chronic stress in animal models of 
major depressive disorder (MDD) (Kempermann and Kronenberg, 2003; Pittenger 
and Duman, 2007), the pharmacological treatment with antidepressants such as 
selective serotonin reuptake inhibitors (SSRI), serotonin and noradrenaline 
reuptake inhibitors (SNRI), restore stress depleted ahNG in these rodent models 
(Eisch and Petrick, 2012). Our interest in antidepressants effect on ahNG was even 
more substantiated when their modulation of ahNG was confirmed also in 
postmortem human brain. Interestingly, the number of proliferative cells is 
increased in the SGZ of patients diagnosed for MDD and treated with SSRI 
(Boldrini et al., 2009). The neurogenic hypothesis of depression stated that 
"increased adult hippocampal neurogenesis is required for the onset of 
antidepressants therapeutic action" (Eisch and Petrick, 2012). Notably, more 
complexity was added to this hypothesis with the discovery that different serotonin 
receptors targeted by antidepressants have distinct and even opposite role in ahNG 
(Klempin et al., 2010). Trazodone is a serotonin antagonist and reuptake inhibitor 
(SARI) antidepressant (Stahl, 2009). Our interest in trazodone lies in its peculiar 
binding affinities to different serotonin and adrenergic receptors and its activity as 
an agonist or antagonist. Trazodone is a well-tolerated drug with also several off-
label uses including hypnosis. It is still not known if trazodone is a proneurogenic 
multimodal antidepressant and how its multimodal activity on serotonin receptors 
could mediate its potential effect. In chapter IV we present a work under 
preparation for publication where we focused on: (i) investigating the effect of 
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trazodone on ahNPC neuronal differentiation, (ii) evaluated the mechanism by 
which trazodone exert its effect and (ii) studied potential downstream signaling 
required for trazodone activity.
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Abstract   
In previous work, we demonstrated that NF-κB p50 acts as crucial regulator of 
adult hippocampal neural progenitor cells (ahNPC). Indeed, NF-κB p50 knockout 
(KO) mice are characterized by remarkably reduced hippocampal neurogenesis. As 
a follow, up to that work, herein we show that when cultured in vitro, ahNPC from 
wild type (WT) and p50KO mice are not significantly different in their neurogenic 
potential. This observation prompted us to investigate cell-autonomous and non 
cell-autonomous consequences of p50 absence on neuronal fate specification of 
ahNPC. In particular, we focused our attention on astrocytes, known to provide 
soluble pro-neurogenic signals, and investigated the influence of WT and p50KO 
astrocyte conditioned media (ACM) on WT and p50KO ahNPC differentiation. 
Interestingly, while WT ACM promoted both neuronal and astroglial 
differentiation, p50KO ACM only supported astroglial differentiation of WT 
ahNPC. By using a LC-MS/MS approach we identified some proteins which are 
significantly upregulated in p50KO compared to WT astrocytes. Among them, 
lipocalin-2 (LCN-2) was recognized as a novel astroglial-derived signal regulating 
neuronal fate specification of ahNPC. Interestingly, LCN-2 pro-neurogenic effect 
was greatly reduced in p50KO NPC, where LCN-2 receptor gene expression 
appeared downregulated. In addition to that, we demonstrated p50KO NPC 
unresponsiveness to both neuronal and astroglial fate specification signals from 
WT and p50KO ACM, and we identified reduced expression of α2δ1, a 
thrombospondin-1 receptor, as another phenotypic change occurring in ahNPC in 
absence of p50. Altogether our data suggest that dysregulated NPC-astrocyte 
communication may contribute to reduced hippocampal neurogenesis in p50KO 
mice in vivo.   
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Introduction 
Adult neurogenesis occurs in restricted areas of postnatal and adult mammalian 
brain, namely the subventricular zone (SVZ) in the lateral wall of the lateral 
ventricles and the subgranular zone (SGZ) in the dentate gyrus (DG) of the 
hippocampus (Bond et al., 2015; Kempermann et al., 2015; Ming and Song, 2005). 
Recent studies also suggested an additional neurogenic region in the adult 
hypothalamus (Kokoeva et al., 2005). 
Adult hippocampal neurogenesis (ahNG) has attracted great research interest due to 
its potential involvement in critical functions including cognition, mood and 
emotional behavior, stress response (Aimone et al., 2010, 2014; Eisch and Petrik, 
2012; Lacar et al., 2014). Although complex, the molecular mechanisms that 
modulate neurogenesis deserve investigation since this may turn into a better 
understanding of ahNG in brain homeostasis and in 
neuropsychiatric/neurodegenerative disorders where this process is profoundly 
deregulated (Apple et al., 2016; Winner et al., 2011). 
Within the CNS, NF-B pathway activation has been involved in a wide range of 
functions both under physiological and pathological conditions (Kaltschmidt and 
Kaltschmidt, 2009; Mattson and Meffert, 2006; Oikawa et al., 2012). A few years 
ago, our group demonstrated that NF-B proteins are expressed at considerable 
levels in areas of active neurogenesis in the postnatal and adult mouse brain 
(Denis-Donini et al., 2005). Since then, a vast array of information has been 
collected on the complex involvement of NF-B proteins in different aspects of 
postnatal neurogenesis. In particular, several extracellular signals and membrane 
receptors have been identified as being able to affect neural stem cells/neural 
progenitor cells (NSC/NPC) and their progeny via NF-B activation (Meneghini et 
al., 2010, 2013; Rolls et al., 2007; Wada et al., 2006; Widera et al., 2008; Zhang et 
al., 2012). 
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Since the initial observation of NF-B presence in adult neurogenic areas, our 
group further explored the role of these regulatory proteins in adult neurogenesis 
with a specific focus on the NF-B1 (p50) subunit (Bortolotto et al., 2014; Grilli 
and Meneghini, 2012). By taking advantage of p50KO mice (Sha et al., 1995) we 
demonstrated that absence of p50 can deeply affect the in vitro response of adult 
hippocampal NPC (ahNPC) to several endogenous signals (Meneghini et al., 2013) 
and to pro-neurogenic drugs (Valente et al., 2012). In vivo we also proved that 
p50KO mice display a dramatic reduction in adult hippocampal neurogenesis 
which correlated with a selective defect in hippocampal-dependent short-term 
memory (Denis-Donini et al., 2008). Interestingly, in vivo and in vitro the 
proliferation rate of hippocampal NSC/NPC in p50KO mice appeared to be similar 
to that of WT mice. Moreover, the apoptotic rate in the hippocampal region was not 
increased in mutant mice compared to their WT counterpart. A detailed phenotypic 
characterization of newly generated hippocampal cells in p50KO mice suggested 
that absence of the NF-B p50 subunit may trigger a rather selective defect in late 
maturation of newly generated neurons (Denis-Donini et al., 2008).  
Homeostasis of adult neurogenesis requires permissive and instructive signals for 
aNSC/NPC. Several elegant studies have investigated the mechanisms through 
which local environment in the neurogenic niche may control fate specification of 
aNSC/NPC. Among others, a pivotal work demonstrated that astroglial cells which 
can instruct stem cells to adopt a neuronal fate (Song et al., 2002). Since the well 
documented role of NF-B in neuronal but also in non neuronal cells (Brambilla et 
al., 2009; Lian et al., 2015), we recently decided to further dissect the role of NF-
B p50 in the cross-talk between adult neural progenitor cells and astrocytes. 
Exposure of WT and p50KO hippocampal NPC to conditioned media from WT 
and p50KO astrocytes was utilized as a strategy to study the potential influence of 
astroglia on aNPC fate specification and the cell autonomous or non cell-
autonomous role played by NF-B p50 signaling in that context.  
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Materials and Methods  
Animals. Wild type (WT; C57BL/6; The Jackson Laboratories) and NF-κB p50-/- 
(p50KO; C57BL/6 
Nfkb1tm1Bal/J; The Jackson Laboratories) mice were housed under light- and 
temperature-controlled conditions in high-efficiency particulate air (HEPA)-filtered 
Thoren units (Thoren Caging Systems) at the University of Piemonte Orientale 
animal facility. Mice were kept 3-4/cage with ad libitum access to water and food. 
Animal care and handling were performed in accordance with European 
Community Directive and approved by the local IACUC (Institutional Animal Care 
and Use Committees). 
Isolation and culture of WT and p50KO adult mouse hippocampal neural 
progenitor cells (NPC). For preparing NPC primary cultures from hippocampi, 
three adult (3-4-month-old) male WT and p50KO mice were sacrificed and cell 
suspension was prepared. Briefly, the brains were removed, and hippocampi were 
isolated and collected in ice-cold PIPES buffer pH 7.4 containing 20 mM PIPES, 
25 mM glucose, 0.5 M KCl, 0.12 M NaCl (Sigma-Aldrich), and 100 U/100 µg/ml 
Penicillin/Streptomycin solution (Life Technologies). After centrifugation 5 min at 
110 x g, the tissue was digested for 40 min at 37°C using the Papain Dissociation 
System (Worthington DBA). Cell suspension was plated onto 25 cm2 cell-culture 
flask (Thermo-Fisher Scientific) and cultured as floating neurospheres through 
subsequent passages (Valente et al., 2012). Primary (Passage 1, P1) neurospheres 
were dissociated after 7-10 days in vitro (DIV), whereas P2-P30 neurospheres 
every 5 DIV. At each passage cells were plated in T25 flask at a density of 12,000 
cells/cm2 in growing medium: Neurobasal-A medium, supplemented with B27 
supplement, 2 mM L-glutamine (Life Technologies), human Epidermal Growth 
Factor (hEGF, 20 ng/ml; Peprotech), basic Fibroblast Growth Factor (bFGF, 10 
ng/ml; Peprotech) and Heparin sodium salt (0.0004 %, Sigma-Aldrich).  
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Adult hippocampal NPC differentiation. NPC (P5-P30) were used for 
differentiation experiments. Briefly, neurospheres were dissociated into single cells 
and plated onto laminin-coated Lab-Tek 8-well permanox chamber slides (Nunc) at 
a density of 47,000 cells/cm2 in NPC differentiation medium (NDM, Neurobasal-A 
medium supplemented with B27, 2 mM L-glutamine and 100 U/100 µg/ml 
Penicillin/Streptomycin). NPC were treated in presence of hippocampal astrocyte 
conditioned media (ACM) derived from WT or NF-κB p50KO glial cultures, or in 
presence of NDM (referred to as standard, STD medium) for 24 h. WT NPC were 
treated in presence of 0.01–1 µg/ml recombinant mouse lipocalin-2 (LCN2, Cell 
Signaling), 2 µg/ml purified human Thrombospondin-1 (hTSP1, Amsbio), or 
corresponding vehicle for 24 h. For RAGE inhibition, 60 min before ACM or 
NDM treatment, 20 μg/ml neutralizing polyclonal anti-RAGE antibody (α-RAGE 
Ab; R&D System) was added to NPC. 
Primary Astrocyte Cultures. Primary mixed glial cultures were prepared from 
hippocampus of neonatal (P1-2) C57BL/6 WT and p50KO mice and grown in 
DMEM high glucose, 10% FBS, 15 mM HEPES, 2 mM L-glutamine and 100 
U/100 µg/ml Penicillin/Streptomycin at a density of 78,000 cells/cm2. When cells 
reached confluence (around 10-12 DIV), proliferation of non-astrocytic cells was 
blocked by 10 µM cytosine arabinoside (Sigma-Aldrich) for 96 h. Then cultures 
were switched to NDM. Phenotypic characterization of cultures was performed by 
immunocytochemistry with antibodies against GFAP (mouse monoclonal, 1:600, 
Millipore) and CD11b (rat monoclonal; 1:150, Millipore). Contaminating 
microglial cells were below 3% of total cells, with the remaining cells being 
GFAP+. Astrocyte-conditioned medium (ACM) was collected after 48h in presence 
of NDM. Briefly, ACM was centrifuged for 10 min at 16,000 x g to eliminate cells 
and debris and passed through 0.2 μm filter before use. ACM was used diluted 1:2 
in fresh NDM.  
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Immunolocalization studies in differentiated adult hippocampal NPC. NPC were 
treated in presence of WT or p50KO ACM or STD medium for 24 h. Phenotypic 
characterization of NPC-derived cells was carried out by immunolocalization for 
MAP-2 (rabbit polyclonal, 1:600; Millipore), GFAP (mouse monoclonal, 1:600; 
Millipore), nestin (chicken monoclonal, 1: 1,500; Neuromics), NG-2 (rabbit 
polyclonal, 1:500; Millipore). Secondary antibodies were as follows: Alexa Fluor 
555-conjugated goat anti-rabbit (1:1,400; Molecular Probes); Alexa Fluor 488-
conjugated goat anti-chicken antibody (1: 1,400; Molecular Probes); Alexa Fluor 
488-conjugated goat anti-rabbit (1: 1,400; Molecular Probes), Alexa Fluor 488-
conjugated goat anti-mouse (1: 1,600; Molecular Probes). Nuclei were 
counterstained with 0.8 ng/ml Hoechst (Thermo Fisher scientific) diluted in PBS. 
In each experiment, 5 fields/well (corresponding to about 150-200 cells/well) were 
counted with a 60X objective by a Leica DMIRB inverted fluorescence 
microscope. Cells positive for each marker were counted and their percentage over 
total viable cells was calculated. All experiments were run in triplicates using 
different cell preparations and repeated at least three times. 
LC-MS/MS analysis and protein quantification. WT and p50KO ACM were 
subjected to TCA precipitation. Briefly, TCA was added to a final 12% (wt/vol) 
concentration and kept on ice for 2 h, followed by centrifugation (16,000 x g, 10 
min). The supernatant was carefully removed, and 1 ml of tetrahydrofuran (pre-
cooled in ice) was added to each pellet and vortexing was carried out until the 
pellet dissolved completely. Proteins were then reduced with dithiothreitol (DTT), 
alkylated by iodoacetamide, and digested with trypsin at 37°C O/N. Data 
acquisition was performed with a micro-LC Eksigent Technologies (Dublin, USA) 
system, with as stationary phase a Halo Fused C18 column (0.5 x 100 mm, 2.7 µm; 
Eksigent Technologies Dublin, USA), interfaced with a Triple-TOF 5600+ system 
(AB Sciex, Concord, Canada) equipped with a DuoSpray Ion source. The mobile 
phase was a mixture of 0.1% (v/v) formic acid in water (A) and 0.1% (v/v) formic 
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acid in acetonitrile (B), eluting at a flow-rate of 15.0 mL min-1 at an increasing 
concentration of solvent B from 2% to 40 % in 30 minutes. An initial data-
dependent acquisition (DDA) analysis was performed on the p50KO and WT ACM 
samples to generate the SWATH-MS spectral library: the mass spectrometer 
analysis was performed using a mass range of 100–1500 Da (TOF scan with an 
accumulation time of 0.25 s), followed by a MS/MS product ion scan from 200 to 
1250 Da (accumulation time of 5.0 ms) with the abundance threshold set at 30 cps 
(35 candidate ions can be monitored during every cycle). The samples were then 
subjected to cyclic data independent analysis (DIA) of the mass spectra, using a 25-
Da window: the mass spectrometer was operated such that a 50-ms survey scan 
(TOF-MS) was performed and subsequent MS/MS experiments were performed on 
all precursors. These MS/MS experiments were performed in a cyclic manner using 
an accumulation time of 40 ms per 25-Da swath (36 swaths total) for a total cycle 
time of 1.5408 s (Geromanos et al., 2009; Gillet et al., 2012; Venable et al., 2004). 
The ions were fragmented for each MS/MS experiment in the collision cell using 
the rolling collision energy. The MS data were acquired with Analyst TF 1.7 (AB 
SCIEX, Concord, Canada). Three replicates for each sample were subjected to the 
DIA analysis.  The mass spectrometry files were searched using Protein Pilot (AB 
SCIEX, Concord, Canada) and Mascot (Matrix Science Inc., Boston, USA) with 
the following parameters: cysteine alkylation, digestion by trypsin, no special 
factors and False Discovery Rate at 1% for Protein Pilot. For Mascot, the following 
parameters were used: the digestion enzyme selected was trypsin, with 3 missed 
cleavages, a search tolerance of 0.4 Da was specified for the peptide mass 
tolerance, and 0.4 Da for the MS/MS tolerance. The charges of the peptides to 
search for, were set to 2+, 3+ and 4+, the search was set on monoisotopic mass and 
the following modifications were specified for the search: carbamidomethyl 
cysteines as fixed modification and oxidized methionine as variable modification. 
The search was conducted using the UniProt Swiss-Prot database containing mouse 
proteins (version 25.03.2015, containing 41741 sequence entries). Dual filtering 
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criteria for protein identification were employed by combining FDR test from 
target-decoy database search with a cutoff p-value of 0.05, and protein/peptide 
confidence above 95% probability, with a minimum of two unique peptides per 
protein. The label-free quantification was performed with Skyline (MacCoss Lab 
Software, University of Washington) by importing the SWATH-MS runs. The 
library of the identified proteins used for the processing of SWATH data was 
generated by combining the results of the database search performed with Protein 
Pilot and Mascot (Manfredi et al., 2016). The quantification was performed by 
integrating the extracted ion chromatogram of all the unique ions for a given 
peptide and by using MSstats, a Skyline external tool for statistical analysis (Choi 
et al., 2014).  
Western blot analysis. Protein extracts from adult NPC cultures were obtained by 
lysis in 3X vol/vol of ice-cold hypotonic RIPA buffer [50mM Tris-HCl pH 7.5, 
150mM NaCl, 0.5mM EDTA pH 8, 1% (vol/vol) Triton X-100, 1% (wt/vol) SDS, 
10mM NaF, 1mM NaVO4, 1mM DTT, protease inhibitor mix (Sigma-Aldrich)] for 
30 min on ice. To complete the lysis, incubation at -80°C for 3 min followed by 2 
min at 37°C was repeated three times. All lysates were centrifuged at 16,100 x g 
for 10 min at 4°C and supernatants were collected. Protein concentration was 
determined by Bradford assay (Sigma-Aldrich) and equivalent protein amounts 
(25μg) were separated by SDS-PAGE gel (6%) and transferred onto nitrocellulose 
membranes. The membranes were blocked with 5% BSA in TBS (Sigma-Aldrich) 
buffer for 60 min at RT. Immunoblots were carried out overnight in an antibody 
solution containing 3% (wt/vol) BSA in TBS-tween 0.1% with the primary 
antibody against the α2δ subunit of Dihydropyridine (DHP)/Thrombospondin-1 
receptor (1:500; Sigma-Aldrich). After washing, blots were incubated with 
peroxidase-conjugated goat anti-mouse antibody (1: 10,000; BIO-RAD) for 60 min 
at RT and immunocomplexes were visualized by the Supersignal West Pico 
Chemiluminescent substrate (Pierce). Densitometric analysis was performed using 
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the Image Lab software system (Bio-Rad Laboratories) and each band was 
normalized to β-actin signal (mouse monoclonal, 1: 1,000; Sigma-Aldrich). 
Quantitative reverse transcriptase PCR (qRT-PCR). RNA was extracted and 
cDNA generated using Transcriptor First Strand cDNA Synthesis Kit (Roche 
Diagnostics GmbH, Penzberg, Germany). qRT-PCR was performed using iTaq 
Universal SYBR Green Supermix (Bio-Rad), and the CFX384 Real-Time PCR 
Detection System (Bio-Rad). The following qRT-PCR primer pairs were used 
(KiCqStart® SYBR® Green Primers Predesigned): for LCN-2 receptor (LCN-
2R/24p3R), 5′-CATTATGGCTCTTCGGTTTC-3′ (forward), 5′-
TAGAAATCGCCAGTCCTTAG-3′ (reverse); for β-actin, 5’-
GATGTATGAAGGCTTTGGTC-3’ (forward), 5’-
TGTGCACTTTTATTGGTCTC -3’ (reverse). LCN-2R/24p3R expression levels 
were normalized against β-actin as housekeeping gene and their relative ratio was 
calculated. 
Statistical analysis. All experiments were run in triplicates using different cell 
preparations and repeated at least three times. Data were calculated as mean ± S.D. 
and analyzed using Student’s t-test when only two independent groups were 
compared, or by one-way analysis of variance (ANOVA) followed by Tukey’s 
post-hoc test when three or more groups were compared. Statistical significance 
level was set for P values < 0.05. 
 
 
Results 
In vitro WT and p50KO ahNPC do not show differences in differentiation and 
survival rates.  
CHAPTER III 
94 
 
Multipotent nestin+, sox2+ and GFAP- NPC isolated from adult mouse hippocampi 
can be maintained for several passages in an undifferentiated proliferative state 
(Cuccurazzu et al., 2013). When grown onto laminin-coated chamber slides, upon 
removal of growth factors and exposure to a serum-free defined medium (STD 
medium), NPC stop dividing and spontaneously differentiate toward both neuronal 
and glial lineages. As previously published, by double immunolabeling for markers 
of neuronal cells (MAP-2) and undifferentiated progenitors (nestin), the appearance 
of newly generated MAP-2+/nestin- neurons and MAP-2+/nestin+ neuroblasts can 
be evaluated and quantified (Meneghini et al., 2013). Under these experimental 
conditions, both WT and p50KO derived NPC gave rise to the same percentage of 
neurons and neuroblasts (mean %  S.D. of MAP-2+/nestin- cells: 3.1 ± 0.6 and 3.3 
± 0.8 for WT and p50KO NPC; MAP-2+/nestin+ cells: 32.2 ± 3.2 and 33.1 ± 2.2 for 
WT and p50KO NPC; Fig. 1). When exposed to STD medium in absence of 
growth factors, ahNPC spontaneously differentiate also toward the astrocytic 
lineage (Meneghini et al., 2013). The percentage of astrocytes (GFAP+ cells) 
generated in vitro by WT and p50KO NPC was not different (mean %  S.D. of 
GFAP+ cells: 16 ± 1.7 and 14.2 ± 2.6 for WT and p50KO NPC; Fig. 1). Finally, no 
significant difference in the basal apoptotic rate could be observed between the two 
genotypes (11.8 ± 6.5 and 12.4 ± 5.9 % for WT and p50KO NPC, respectively).  
Effect of WT- and p50KO-derived astrocyte-conditioned media (ACM) on neuronal 
differentiation of WT ahNPC cultures. 
We investigated the possibility that non cell-autonomous effects were contributing 
to remarkably reduced hippocampal neurogenesis in p50KO mice (Denis-Donini et 
al., 2008). 
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Since soluble factors released by astrocytes have been shown to modulate 
differentiation of NPC (Song et al., 2002), we evaluated their effect on the 
differentiation rate of ahNPC toward neuronal and non-neuronal lineages. Primary 
mixed glial cultures were prepared from hippocampi of neonatal (P1-2) WT and 
p50KO mice. When cells reached confluence, proliferation of non-astrocytic cells 
was blocked by 10 µM cytosine arabinoside so to obtain an astrocytic-enriched cell 
population with less than 3% of contaminating microglia. Astrocyte-conditioned 
medium (ACM) was added to WT ahNPC cultures. Under these experimental 
conditions, we tested the effect of WT and p50KO ACM, in comparison with 
standard differentiation (STD) medium, on NPC neuronal differentiation. After 24 
FIGURE 1. Adult hippocampal NPC derived from WT and p50KO mice show 
similar in vitro neuronal and glial differentiation rates. Under differentiating 
conditions, WT and p50KO ahNPC spontaneously give rise to similar percentages of 
MAP-2+/nestin-
 
neurons, MAP-2+/nestin+
 
neuroblasts and GFAP+ astrocytes. Data are 
expressed as mean % ± S.D. of n = 4 experiments, run in triplicates, and analyzed by 
Student’s t-test. 
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h, a significant increase in the percentage of in vitro generated neurons and 
neuroblasts was observed in WT cells exposed to WT-derived ACM, compared to 
STD medium condition (% increase over STD medium-treated cells: +93.8  43.3 
for MAP-2+/nestin- cells, P < 0.001; +36.6  23.3 for MAP-2+/nestin+ cells, P < 
0.001; Fig. 2A, B). Under the same in vitro experimental conditions, no significant 
difference was observed between WT NPC treated with STD medium or p50KO 
ACM on both neuron and neuroblast subpopulations (Fig. 2A, B). To investigate 
whether ACM could affect cell survival in addition to neuronal differentiation, we 
analyzed the apoptotic rate of ahNPC and their progeny. No difference in the 
percentage of apoptotic cells was observed in the different media conditions (Fig. 
2C).  
Both WT- and p50KO-derived ACM significantly promote astroglial differentiation 
of WT ahNPC. 
We then tested the effect of ACM on astroglial differentiation of ahNPC.  We 
observed a significant increase in the percentage of GFAP+ cells being generated in 
vitro when WT NPC were exposed to both WT and p50KO ACM (% increase over 
STD medium: +130.2  28.1 and +180  44.8 for WT and p50KO ACM, 
respectively; P < 0.001; Fig. 3A). Actually, in our experimental setting p50KO 
ACM was more effective than WT ACM in promoting astrogliogenesis (Tukey 
post hoc, P < 0.01; Fig. 3A). A subpopulation of NG-2+ cells is also present both in 
proliferating and differentiating conditions in our cellular model. NG-2+ cells, also 
known as polydendrocytes, are commonly regarded as oligodendrocyte precursor 
cells (Nishiyama et al., 2009) but also, although controversial, as multipotential 
progenitors (Kondo and Raff, 2000). Interestingly, under differentiating conditions, 
the percentage of NG-2+ cells was not different in presence of STD, WT ACM and 
p50KO ACM (Fig. 3B).  
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FIGURE 2. WT, but not p50KO ACM, promote neuronal differentiation of WT 
ahNPC cultures. (A-B) Under differentiating conditions, 24h treatment of WT 
hippocampal NPC with WT ACM significantly increased the percentage of MAP-
2+/nestin-
 
neurons (A) and MAP-2+/nestin+
 
neuroblasts (B) compared with standard 
differentiation medium (STD). Conversely, p50KO ACM was devoid of any pro-
neurogenic effect. (C) No significant difference was observed in the apoptotic rate of 
cultures exposed to STD medium, WT and p50KO ACM. (D-F) Representative confocal 
microscopy images of MAP-2+ cells (green, white arrowheads) generated from ahNPC 
after 24h in presence of STD medium (D), WT ACM (E) and p50KO ACM (F). Nuclei 
were counterstained with Hoechst (blue). Magnification = 400X. Scale bar = 20 μm. Data 
were calculated as mean values ± S.D. of n = 3 experiments, run in triplicates and 
analyzed by one-way ANOVA followed by Tukey’s post hoc test. ***P < 0.001 versus 
STD; ### P < 0.001 versus WT ACM. Data are expressed as % of increase over STD 
treated cells. 
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p50KO NPC are unresponsive to neuronal and astroglial differentiation signals 
from both WT- and p50KO astrocytes  
We then tested the effect of WT and p50KO ACM on p50KO NPC differentiation 
toward neuronal and non-neuronal lineages. Surprisingly, neither WT nor p50KO 
ACM promoted neuronal differentiation of KO NPC, and their effect was 
indistinguishable from that of STD medium (Fig. 4A, B). In addition, unlike WT 
NPC, KO NPC did not even respond to the astrogliogenic effects of WT and KO 
ACM (Fig. 4C). Similarly, to what observed in WT NPC, we could not observe any 
difference in the percentage of NG-2+ cells when p50KO NPC were exposed to 
different media conditions (Fig. 4D). Finally, also in p50KO cultures apoptotic 
rates were not different in presence of the different media conditions (data not 
shown).  
The Receptor for Advanced Glycated End-products (RAGE) is not involved in the 
pro-neurogenic activity of ACM on WT ahNPC differentiation. 
RAGE is functionally expressed by ahNPC (Meneghini et al., 2010) and its 
activation by astrocytes released molecules, like HMGB-1 and S100B, promotes 
neuronal differentiation of ahNPC (Meneghini et al., 2013). In order to understand 
if the activation of RAGE could mediate the pro-neurogenic activity of WT ACM 
on WT ahNPC we pre-treated cultures with a neutralizing anti-RAGE antibody (α-
RAGE Ab, 20 μg/ml). α-RAGE Ab was not able to block the increase of MAP-2+ 
cells induced by WT ACM (% increase over STD medium: +70.07 ± 24 for WT 
ACM, P < 0.001; +50.6 ± 27.8 for WT ACM + α-RAGE Ab, P < 0.01; Fig. 5A).  
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FIGURE 3. Both WT and p50KO ACM promote astroglial differentiation of WT 
ahNPC. (A) 24h treatment of WT ahNPC with WT and p50KO ACM significantly 
increased the percentage of GFAP+
 
astroglial cells, compared with STD medium. p50KO 
ACM was more effective on astrogliogenesis than WT ACM. (B) No significant 
differences were observed in the percentage of NG-2+ cells upon exposure to different 
media conditions. (C-H) Representative confocal microscopy images of ahNPC cultures 
differentiated in presence of STD (C, F), WT ACM (D, G) and p50KO ACM (E, H), and 
immunolabelled for GFAP (C-E) and NG-2 (F-H). Nuclei were counterstained with 
Hoechst (blue). Magnification = 400X. Scale bar = 20 μm. Data were calculated as mean 
values ± S.D. of n = 3 experiments, run in triplicates and analyzed by one-way ANOVA 
followed by Tukey’s post hoc test.***P < 0.001 versus STD; ##P < 0.01 versus WT ACM. 
Data are expressed as % of increase over STD treated cells. 
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p50KO NPC are defective in their response to thrombospondin-1 and display 
downregulated α2δ1 expression.  
FIGURE 4. p50KO ahNPC are unresponsive to neuronal and astroglial 
differentiation signals from both WT and p50KO astrocytes. (A-B) Under 
differentiating conditions, 24h treatment of p50KO hippocampal NPC with WT and 
p50KO ACM did not affect the percentage of MAP-2+/nestin- neurons (A) and MAP-
2+/nestin+ neuroblasts (B), compared to STD condition. (C-D) No significant difference 
was observed in the percentage of GFAP+ cells (C), and NG-2+ cells (D) in presence of 
STD medium, WT and p50KO ACM. Data are expressed as mean values ± S.D. of n = 3 
experiments, run in triplicates. Data were analyzed by one-way ANOVA followed by 
Tukey’s post hoc test.  
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Thrombospondin-1 (TSP-1) is an astrocyte-derived pro-neurogenic factor (Lu and 
Kipnis, 2010). Recently our group demonstrated that 2, a thrombospondin-1 
(TSP-1) receptor (Eroglu et al., 2009), is functionally expressed by ahNPC 
(Valente et al., 2012). Recombinant human TSP-1 (2 g/ml) promoted an increase 
in the percentage of newly formed neurons in WT NPC cultures, when compared to 
vehicle (% increase over vehicle: +71.7 ± 29.5 in TSP-1-treated cells; P < 0.001; 
Fig. 5B). Conversely, TSP-1 treatment was ineffective in p50KO NPC (Fig. 5B). 
Then we evaluated α2δ1 expression levels in WT and p50KO ahNPC by western 
blot analysis. Interestingly, the α2δ1 subunit appeared strongly downregulated in 
p50KO compared with WT NPC (-59.5%; P < 0.05, Fig. 5C). 
Proteomic analysis of soluble factors released by WT and p50KO ACM 
In order to identify proteins which are secreted by WT and p50KO astrocytes, we 
analyzed ACM samples using a proteomic approach based on a hybrid system that 
combines the triple quadrupole technology with a time of flight mass spectrometer 
platform (Andrews et al., 2011). The analysis was performed on peptides produced 
by tryptic digestion of ACM proteins. Each sample was injected separately into the 
HPCL columns in a data dependent acquisition mode in order to build the spectra 
library of proteins identified from the runs. The protein spectra were then subjected 
to SWATH (Sequential Window Acquisition of Theoretical mass spectra) analysis, 
that allows complete evaluation of fragmented ions from detectable peptides in 
biological samples. Through this approach, we were able to identify and quantify, 
as listed in Table 1, three proteins which were differentially expressed in WT and 
p50KO ACM, with P values below 0.05. Specifically, the following proteins 
appeared upregulated in p50KO compared to WT ACM: neutrophil gelatinase-
associated lipocalin-2 (NGAL/LCN-2), C-C motif chemochine-2 (CCL2), H-2 
class I Histocompatibility antigen, K-K alpha chain (HA1K). Fold-change increase 
of each identified protein in p50KO ACM vs WT ACM is reported in Table 1.   
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FIGURE 5. p50KO NPC are defective in their pro-neurogenic response to 
thrombospondin-1 and display downregulated expression of α2δ1. (A) RAGE 
activation does not mediate the proneurogenic effects of WT ACM. Pretreatment with a 
neutralizing anti-RAGE antibody (20 μg/ml) does not counteract the pro-neurogenic 
effects of WT ACM on WT ahNPC, as assessed by MAP-2+ counting. (B) Under 
differentiating conditions, 24 h treatment of WT NPC with human recombinant TSP-1 (2 
µg/ml) significantly increased the percentage of MAP-2+/nestin- cells, compared to 
vehicle. No effect was observed in TSP-1-treated p50KO NPC. Data have been calculated 
as mean values ± S.D. of n = 4 experiments, run in triplicates. *** P < 0.001 versus vehicle 
(Tukey’s post hoc test). Data are expressed as % of increase over vehicle-treated cells. (C) 
Representative immunoblot analysis of α2δ1 subunit and β-actin expression levels in 
extracts of undifferentiated WT and p50KO ahNPC. Three (1-3) different WT and 
p50KO cell preparations were collected at different passages and analyzed.  
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Lipocalin-2 is an astrocyte-derived pro-neurogenic factor whose activity is 
strongly reduced in p50KO NPC. 
Lipocalin-2 (LCN-2) is 24 kDa iron-related protein whose modulatory role for 
diverse cell phenotypes in the CNS has recently attracted interest (Jha et al., 2015). 
Since no data are currently available on the role of LCN-2 on adult neurogenesis 
we focused our attention on this upregulated protein as a potential contributor to 
the absence of pro-neurogenic effects by p50KO ACM. We tested recombinant 
mouse LCN-2 (0.01-1 µg/ml) initially on differentiating WT ahNPC. To our 
surprise LCN-2 promoted, in a concentration-dependent manner, neuronal 
differentiation of WT NPC, as assessed by counting the percentages of MAP-
2+/nestin- cells generated in presence of recombinant protein or vehicle (One-way 
ANOVA; P < 0.001, Fig. 6A). Maximal pro-neurogenic effect was elicited in 
presence of 0.1 µg/ml LCN-2 (% increase over vehicle-treated cells: +86.78 ± 
29.18, P < 0.001; Fig. 6A). When tested on p50KO NPC LCN-2 was ineffective up 
to 0.3 µg/ml and only 1 µg/ml of protein significantly increased the percentage of 
newly generated neurons (% of increase over vehicle-treated cells: +70.27 ± 31.1, 
P < 0.001; Fig. 6A). Under the same concentration range, LCN-2 had no effect on 
cell survival in both genotypes (Fig. 6B). We then evaluated mRNA levels for 
LCN-2 receptor (24p3R) and β-actin in WT and p50KO NPC by qRT-PCR. qRT-
PCR analysis showed that LCN-2R/24p3R gene expression is markedly reduced in 
p50KO compared to WT cells (% reduction: -64.4 ± 2.4, Student’s t-test: ** P < 
0.01; Fig. 6C).  
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Discussion 
In recent years, experimental data on the involvement of NF-B proteins in the 
regulation of adult neurogenesis have been generated (as reviewed in Grilli and 
Meneghini, 2012; Bortolotto et al., 2014). A few years ago, our group proved that 
p50KO mice display a dramatic reduction in adult hippocampal neurogenesis and, 
in parallel, a selective defect in hippocampal-dependent short-term memory. A 
detailed phenotypic characterization of newly generated hippocampal cells strongly 
FIGURE 6. Lipocalin-2 is a novel astrocyte-derived pro-neurogenic signal whose 
activity is reduced in p50KO NPC. (A) 24 h treatment with mouse LCN-2 (0.01-1 
µg/ml) promoted neuronal differentiation of WT ahNPC in a concentration-dependent 
manner. Under the same experimental conditions, p50KO NPC responsiveness to LCN-
2 is significantly reduced. (B) LCN-2 has no effect on the survival rate of WT and 
p50KO NPC and their progeny. Data were calculated as mean values ± S.D. of n = 3 
experiments, run in triplicates, and analyzed by one-way ANOVA, followed by Tukey’s 
post hoc test. **P < 0.01, ***   P < 0.001 versus WT vehicle; ## P < 0.01, ### P <0.001 
versus p50KO vehicle; §§ P < 0.01, §§§ P < 0.001 in WT vs P50KO NPC. Data are 
expressed as % of increase over vehicle-treated cells. (C) QRT-PCR evaluation of LCN-
2R/24p3R expression levels in WT and p50KO NPC. LCN-2R expression levels were 
normalized against β-actin as housekeeping gene and their relative ratio was calculated. 
LCN-2R expression was downregulated in p50KO NPC. ** P < 0.01 vs WT NPC, 
Student’s t-test.   
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suggested that lack of p50 is associated with defects in the late maturation of newly 
generated neurons, in absence of alterations in survival and proliferation rates of 
ahNPC (Denis-Donini et al., 2008). As a follow up to that work, herein we show 
that when cultured in vitro, ahNPC from WT and p50KO mice are not significantly 
different in their neurogenic potential. By using double immunocytochemistry, we 
could distinguish two distinct MAP2+ cell populations which are generated in vitro 
by ahNPC: MAP2+/nestin+ cells, which may be indicative of NPC commitment 
toward the neuronal lineage and MAP2+/nestin- cells, which may better reflect 
neuronal maturation. Under basal conditions we could not observe significant 
differences in the two populations between WT and p50KO NPC cultures. 
Altogether we concluded that absence of NF-κB p50 did not correlate in vitro with 
alteration in NPC commitment to neuronal lineage or with maturation of newly 
generated neurons, as observed in vivo (Denis-Donini et al., 2008).  
Since the well documented role of NF-κB in non-neuronal cells (Brambilla et al., 
2009; Lian et al., 2015), we dissected the role of p50 in ahNPC and astrocytes. 
Exposure of WT and p50KO hippocampal NPC to conditioned media from WT 
and p50KO astrocytes was utilized as a strategy to study the influence of astroglia-
generated soluble factors on NPC fate specification and the cell-autonomous or non 
cell-autonomous role played by p50 signaling in that context. Initially we tested the 
effects of WT and p50KO ACM on WT ahNPC. As previously shown (Song et al., 
2002), also in our hands WT ACM promoted neuronal differentiation of ahNPC. 
Additionally, WT primary astrocytes produced soluble factors that promoted 
astrogliogenesis of ahNPC, again in line with published reports (Barkho et al., 
2006; Chang et al., 2003). Interestingly, when ahNPC were exposed to p50KO 
ACM we could not observe pro-neurogenic effects. Conversely, p50KO ACM-
derived astrogliogenic signals appeared intact and even enhanced, compared to WT 
ACM. Of note, no differences in the survival rate of NPC and/or their progeny 
could be observed after exposure to WT or p50KO ACM.  
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One interpretation for the lack of proneurogenic effects elicited by p50KO ACM is 
that absence of the NF-κB subunit could directly affect the secretory profile of 
astrocytes. It could be hypothesized that, in absence of NF-κB p50, primary 
astrocytes either become defective in the production of pro-neurogenic molecule(s) 
or, alternatively, produce antineurogenic molecule(s). In such context, direct and 
indirect effects of p50 absence could be envisioned. p50 absence may indeed affect 
transcription of genes encoding for astrocyte-secreted molecules. This could occur 
as a consequence of the fact that target gene(s) transcription is repressed by p50 
homodimers (in that case the gene would become overexpressed) or because, in 
absence of p50, a profound rearrangement occurs in the available pool of NF-B 
transcriptional dimeric complexes, which may in turn result in activation and/or 
repression of target gene(s). Of course, we cannot even exclude that p50 absence 
may affect astrocyte secretory profile also by altering the expression of genes 
encoding proteins which may influence the activity of secreted proteins via 
posttranscriptional modifications, i.e kinases, phosphatases, proteases. Although 
unlikely, p50 absence may even affect astrocyte secretory pathways or transcription 
of proteins directly participating in secretory mechanisms. Of course, we do not 
disregard the possibility that NF-B p50 absence may change, in addition to their 
secretory profile, other phenotypic features of astrocytes, including receptor 
expression and intracellular signaling pathways, but we did not experimentally 
address this.  
We also tested the effect of WT and p50KO ACM on p50KO NPC differentiation. 
Surprisingly, neither WT nor p50KO ACM promoted neuronal and astroglial 
differentiation of p50KO NPC over basal conditions, suggesting that in absence of 
p50 cell autonomous changes may also occur and affect responsiveness of ahNPC 
to astrocyte-derived pro-neurogenic and astrogliogenic signals.  
In search for phenotypic changes in p50KO NPC which may explain their reduced 
responsiveness to astrocyte-derived pro-neurogenic signals we took into 
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consideration the possibility that these cells may be deficient in membrane 
receptors for astrocyte-derived pro-neurogenic molecules. RAGE, the Receptor for 
Advanced Glycation End-products, is expressed by adult NPC where it mediates 
the pro-neurogenic effects of several molecules like HMGB-1 and S100B which 
are secreted by astrocytes (Meneghini et al., 2010, 2013). Receptor neutralization 
had no effect on WT ACM pro-neurogenic effects, suggesting that RAGE 
activation was not involved in ACM-mediated neuronal differentiation of ahNPC. 
Thrombospondin-1 (TSP-1) is also an established astrocyte-derived pro-neurogenic 
factor (Lu and Kipnis, 2010). Our group demonstrated that α2δ1, a TSP-1 receptor 
(Eroglu et al., 2009), is functionally expressed by ahNPC (Valente et al., 2012). 
Interestingly, α2δ1 expression levels were significantly reduced in p50KO ahNPC, 
compared to their WT counterpart. In line with this observation, TSP-1 promoted 
an increase in the percentage of newly formed neurons in WT, but not in p50KO, 
NPC cultures. Overall these data confirmed that, in absence of p50, cell-
autonomous defects may reduce ahNPC responsiveness to astrocyte-derived pro-
neurogenic signals, and in particular to TSP-1, via downregulation of its receptor.  
We also actively searched for proteins which may be differentially secreted by 
astrocytes in absence of p50 and whose expression could correlate with the lack of 
pro-neurogenic effects of KO ACM. LC-MS/MS allowed us to identify proteins 
differentially expressed in WT and p50KO ACM. More specifically, three 
molecules were upregulated in p50KO compared to WT ACM, namely C-C motif 
chemochine-2 (CCL2), neutrophil gelatinase-associated/lipocalin-2 (NGAL/LCN-
2), H-2 class I Histocompatibility antigen, K-K alpha chain (HA1K). Interestingly, 
absence of NF-B p50 is commonly linked to inflammation in periphery and in 
brain (Bernal et al., 2014; Rolova et al., 2014) and both CCL-2 and LCN-2 share an 
established role in inflammation. Moreover, among them, CCL-2 and LCN-2 are 
both encoded by NF-B target genes and NF-B signaling activation lies 
downstream their receptor activation (Bu et al., 2006; Kohda et al., 2014; Ueda et 
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al., 1994). We hypothesized that one of these proteins may indeed exert anti-
neurogenic activities on NPC and we focused our attention on LCN-2.   
LCN-2 is a 24 kDa iron-related protein whose modulatory role in the CNS has 
recently attracted interest (Jha et al., 2015), although its function is not completely 
understood (Ferreira et al., 2015). LCN-2 is secreted by brain astrocytes and 
regarded as an autocrine promoter of their classical proinflammatory activation (Bi 
et al., 2013; Jang et al., 2013). Since no information was available on the role of 
LCN-2 on adult neurogenesis, we concentrated our attention on this protein, whose 
expression is increased by about threefold in p50KO compared to WT ACM. To 
our surprise, LCN-2 promoted, in a concentration-dependent manner, neuronal 
differentiation of WT NPC. In contrast with previous observations that LCN-2 can 
promote apoptosis of neurons and astrocytes (Lee et al., 2012), in our cellular 
model and within the tested concentration range the protein had no negative effect 
on the survival of ahNPC and their progeny. Under the same experimental 
conditions, LCN-2 had no or little effect on neuronal differentiation of p50KO 
NPC, except at the highest concentration. Altogether, these data suggest, for the 
first time, that LCN-2 is an astroglial-derived signal which promotes neuronal fate 
specification of ahNPC and that p50KO NPC are less responsive to this protein. 
Such reduced sensitivity correlates with downregulation of LCN-2R/24p3R mRNA 
levels in p50KO ahNPC. Although it has been demonstrated that LCN-2R is 
constitutively expressed at high levels in brain, including the hippocampus (Chia et 
al., 2015), to our knowledge this is the first demonstration that this receptor is 
expressed in aNPC. Interestingly, NF-κB signaling activation has been shown to 
occur downstream of LCN-2/24p3R activation (Dizin et al., 2013).  
At this stage of knowledge, we have not yet identified a culprit for reduced pro-
neurogenic effects of p50KO ACM on WT NPC. As far as CCL-2, literature data 
suggested both pro-neurogenic (Liu et al., 2007) and antineurogenic effects (Lee et 
al., 2013) of this chemokine. In our cellular model also CCL-2 exerted pro-
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neurogenic activity (data not shown), suggesting that upregulated expression of this 
chemokine cannot justify reduced pro-neurogenic effects of p50KO ACM on WT 
NPC. H-2 class I Histocompatibility antigen, K-K alpha chain (HA1K) was also 
identified by LC-MS/MS in astrocyte-conditioned media and appeared upregulated 
in p50KO ACM. Of course, at this stage we cannot exclude that its presence in 
media may represent an artefact, but since exosomes bearing MHC Class I 
molecules have been demonstrated in other cell types (Zitvogel et al., 1998), in the 
future we would like to explore the possibility that extracellular 
exosomes/microvesicles of astrocytic origin could contribute, with their cargo, to 
ACM composition and, potentially, to astrocyte-NPC communication. The proteins 
that we identified in ACM by LC-MS/MS is likely to represent a small fraction of 
all astrocyte secreted proteins, so we may have missed other contributors to the 
reduced proneurogenic potential of p50KO ACM. Among NF-B target genes that 
are expressed in astrocytes and whose product is secreted there are indeed many 
additional inflammatory and anti-inflammatory cytokines and chemokines (for 
example, IL-1, IL-6, IL-8, IL-10, IL-12, IL-23, TNF) (Choi et al., 2014), as well as 
growth factors like BDNF (Marini et al, 2014). The role of BDNF in neurogenesis 
is well established, but preliminary experiments in our laboratory did not reveal 
significant differences in its expression levels or its maturation process between 
WT and p50KO astrocytes (data not shown).  
An additional explanation for reduced pro-neurogenic effects of p50KO ACM on 
WT NPC could be that p50KO ACM components may negatively affect expression 
or functionality of receptor(s) for astrocyte-derived pro-neurogenic molecules on 
WT NPC. Since this event occurs in 24 h, internalization/downregulation or 
posttranslational modifications of receptors may potentially take place in WT NPC 
when exposed to p50KO ACM.  
In our experimental setting p50KO NPC were not only unresponsive to pro-
neurogenic but also to astrogliogenic astrocyte-derived signals. In the future, we 
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may also attempt identifying the nature of astrocyte-secreted signals that promote 
astrogliogenesis and of the complex cell-autonomous changes that take place in 
NPC in absence of p50. We cannot exclude that the inability of p50KO NPC to 
respond to both pro-neurogenic and astrogliogenic signals may also depend on p50-
requirement downstream of ACM treatment.  
Altogether we propose that reduced hippocampal neurogenesis in p50KO mice in 
vivo could be ascribed to complex defects in the cross-talk between astrocytes and 
ahNPC. Of course, we cannot exclude the contribution of other cell phenotypes to 
reduced hippocampal neurogenesis in p50KO mice and in particular of microglial 
cells which are well known to affect NPC fate specification (Sierra et al., 2014). 
Our experimental work demonstrates that complex cell autonomous and non cell-
autonomous changes can affect NPC fate specification in absence of NF-B p50. 
We also show, for the first time, that LCN-2 is an astroglial-derived signal which 
promotes neuronal fate specification of ahNPC and whose activity, in parallel with 
a downregulation of LCN-2R, is strongly reduced in p50KO NPC. Altogether, 
these data add further complexity to a growing body of data suggesting the 
relevance of astrocytes and NF-B signaling in the modulation of adult 
neurogenesis.  
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Abstract 
Decreased adult hippocampal neurogenesis (ahNG) is believed to contribute to 
reduced hippocampal volume in major depressive disorder (MDD). Several 
antidepressants (AD) also increase ahNG simultaneously to the onset of the 
therapeutic effect in a rodent model of depression. Trazodone (TZD) is a 
multifunctional antidepressant with off-label uses including hypnosis. It is a dose-
dependent serotonin receptor 5-HT2 antagonist, reuptake inhibitor (SARI), 5-HT1A 
partial agonist and α1 and α2 adrenergic receptor (AR) antagonist. We asked 
whether trazodone is a proneurogenic antidepressant and which are the molecular 
mechanisms underlying its activity. To answer this question, we first assessed the 
expression of receptors involved in TZD pharmacological activity in murine adult 
hippocampal neural progenitor cells (ahNPC). Then we tested TZD activity to 
promote neuronal differentiation of ahNPC in vitro. We found that TZD increases 
neuronal differentiation in a concentration and time-dependent manner. The 
proneurogenic effect was mediated by 5-HT2A and 5-HT2C antagonism. Serotonin 
depletion in ahNPC blunted TZD proneurogenic effect. Moreover NF-𝜅B p50 
subunit presence was required for TZD proneurogenic effect. Altogether we 
concluded that trazodone proneurogenic effect is through 5-HT2A/2C antagonism 
and NF-𝜅B p50 dependent. Our results suggest that ahNG is a pharmacological 
target for trazodone and might be involved in its therapeutic activities. 
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Introduction  
Adult hippocampal neurogenesis (ahNG) is a compelling form of neural plasticity 
susceptible to pharmacological modulation (Duman et al., 2001; Dranovsky and 
Hen, 2006; Xu et al., 2016). Lifelong generation of new neurons in the 
hippocampus takes place in the subgranular zone (SGZ) of the dentate gyrus (DG) 
from a pool of adult hippocampal neural progenitor cells (ahNPC) (Kempermann et 
al., 2003; Zhao et al., 2008; Bond et al., 2015). Newly generated neurons can 
integrate into neuronal networks and contribute to hippocampal-dependent 
learning, memory and to mood regulation (Aimone et al., 2014). The failure of 
ahNG is correlated to cognitive impairment and mood alterations in several 
neuropsychiatric disorders mainly in major depressive disorder (MDD) 
(Kempermann and Kronenberg, 2003; Mirescu and Gould, 2006; Kempermann et 
al., 2008). Notably, acute and chronic stress reduce neuroplasticity at multiple 
levels including ahNPC proliferation and neuronal differentiation (Pittenger and 
Duman, 2007; Eisch and Petrick, 2012). Despite the extensive research studies that 
tried to explain this effect, there is still a lot to discover about the involvement of 
specific receptors in this depletion.  
After being ranked as the second in global disease burden, MDD is also projected 
to be the leading cause worldwide by 2030 (World Health Organization, 2012; 
Manji et al., 2001). Interestingly, pharmacological treatment of MDD with several 
antidepressants (AD), including tricyclic AD (TCA), selective serotonin reuptake 
inhibitors (SSRI) and serotonin and noradrenaline reuptake inhibitors (SNRI), 
restored ahNG to physiological levels in rodent models of MDD-like disorder 
(Pittenger and Duman, 2007; Eisch and Petrick, 2012). Increased number of 
proliferative cells was also reported in a postmortem study on human brain from 
patients diagnosed with MDD and treated with SSRI (Boldrini et al., 2009). These 
findings suggest that positive modulation of ahNG is required for AD effect. 
However, there is more complexity in this hypothesis since distinct serotonin 
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receptor subtypes might contribute diversely and even mediate opposite effects on 
ahNG (Klempin et al., 2013). AhNPC express serotonin receptors 5-HT1A, 5-
HT2C/B and neuron specific serotonin synthesis enzyme tryptophan hydroxylase 
(TPH2) (Benninghoff et al., 2010). Research studies showed that 5-HT1A agonists 
increase ahNPC proliferation (Banasr et al., 2003) whereas 5-HT2 agonists 
decreased ahNPC neuronal differentiation in mice (Klempin et al. 2010). Despite 
extensive research on positive modulation of ahNG by antidepressants, little is 
explored on the role of 5-HT receptors targeted by AD on ahNPC differentiation 
and apoptosis. The complexity of these systems in vivo contributed to the scarce 
precision in this context. 
More than 50% of patients diagnosed for MDD quit antidepressant therapy due to 
side effects or unresponsiveness (Hunot et al., 2007; Duman et al., 2016). 
Trazodone is a triazolopyridine derivative multimodal AD. Trazodone is a dose-
dependent 5-HT2A/2C antagonist and serotonin reuptake transporter (SERT) 
inhibitor (SARI) (Stahl et al., 2009). Moreover, trazodone is a 5-HT1A partial 
agonist and has binding affinities for α1 and α2 adrenergic receptors (AR), 
histamine receptor 1 (H1) with minimal anticholinergic activity (Knight et al., 
2004; Stahl, 2009). Several studies described the therapeutic effect of trazodone as 
a well-tolerated antidepressant, commonly also prescribed as add-on hypnotic drug 
to improve sleep disorders (Saletu-Zyhlarz et al., 2003; Stahl et al., 2009). 
However, it is not known if trazodone characterized as multimodal antidepressant 
is a positive modulator of ahNG and which mechanisms are employed in this 
effect.  
 In our study, we used a well characterized simplified in vitro model of ahNPC to 
determine whether trazodone modulate their proliferation, neuronal and non-
neuronal differentiation and survival. We also investigated the receptors and 
downstream signaling pathways potentially involved in the in vitro effect of 
trazodone.  
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Materials and methods  
Animals. Male C57BL/6 Wild type (WT; C57BL/6, The Jackson Laboratories, US) 
and NF-κB p50-/- (p50KO; C57BL/6 Nfkb1tm1Bal/J; The Jackson Laboratories, 
US) mice were acclimated under light- and temperature-controlled conditions in 
high efficiency particulate air (HEPA)- filtered Thoren units (Thoren Caging 
System, Hazelton, PA). Mice were housed in number of 3-4/cage with ad libitum 
access to food and water at the animal facility of University of Piemonte Orientale. 
Animal care and handling were carried out according to protocols approved by the 
European Community Directive and the local Institutional Animal Care and Use 
Committees (IACUC). 
Drugs. All drugs concentrations were chosen based on binding affinity to target 
receptors. The sources of compounds were as follows: 5-Hydroxytryptamine 
hydrochloride (5-HT); 2-[3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl]-1,2,4-
triazolo[4,3-a]pyridin-3(2H)-one HCl, a full 5-HT2C receptor agonist (Trazodone, 
TZD); Venlafaxine HCl, a 5-HT and noradrenaline (NE) RI (SNRI, VEN); DL-P-
Chlorophenylalanine, an irreversible tryptophan hydroxylase inhibitor (PCPA); 
Phenylephrine HCl, an α1 AR agonist (PHE) were purchased from Sigma-Aldrich, 
Milan. IT8,9-Dichloro-2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)-
one HCl, a selective and potent 5-HT2C antagonist (WAY161503); (4-Bromo-3,6-
dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide, a high affinity 5-
HT2A agonist (TCB-2); (2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-
piperidinyl)ethyl]pyrrolidine HCl, a 5-HT7 receptor antagonist (SB 269970); (3R)-
3-(Dicyclobutylamino)-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide 
HCl, a high affinity and selective 5-HT1A antagonist (NAD 299); idazoxan, an α2 
AR antagonist (IDZ) were purchased from Tocris (Bioscience, Bristol, UK) 
distributed by Space import export, Milan, IT.  
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Isolation and culture of adult hippocampal Neural Progenitor Cells (NPC). Adult 
murine hippocampal NPC were isolated WT and p50KO mice as previously shown 
(Meneghini et al., 2014). Briefly, for each culture preparation three adult male mice 
(3-4-month-old) were euthanized by cervical dislocation. Brains were removed and 
hippocampi were dissected out and collected in ice-cold PIPES buffer pH 7.4 
containing 20 mM PIPES, 25 mM Glucose, 0.5 M KCl, 0.12 M NaCl (Sigma-
Aldrich) and 100 U/100 μg/ml of penicillin/streptomycin (Pen/Strep, Gibco, Life 
Technologies, Monza, IT). After centrifugation for 10 min at 110 x g, tissue was 
digested for 40 minutes (min) at 37⁰C with Papain Dissociation System 
(Worthington DBA, Lakewood, NJ). Cell suspension was cultured in NUNC 
EasYFlask 25 cm2 (Thermo Scientific, Waltham, MA) with serum-free complete 
proliferation medium containing Neurobasal-A supplemented with B27, 2 mM 
glutamine (Gibco), 20 ng/ml recombinant human Epidermal Growth Factor 
(rhEGF), 10 ng/ml of recombinant human basic Fibroblast Growth Factor 
(rhbFGF/FGF-2, PeproTech, Rocky Hill, NJ), 4 μg/ml heparin sodium salt (Sigma-
Aldrich), and 100 U/100 μg/ml of Pen/Strep (Gibco). Passage 1 (P1) neurospheres 
were dissociated for the first time after ten days in vitro (DIV). From P2, 
dissociation was performed every five days and NPC were replated at a density of 
12,000 cells/cm2. NPC were used for experiments from P5 to P30. Proliferating 
NPC were routinely tested for their undifferentiated state by expression of sox-2 
(Sry-related HMG box transcription factor) and nestin (Type VI intermediate 
filament).  
For irreversible inhibition of tryptophan hydroxylase (TPH2), cells were treated 
with 50 μM of PCPA or vehicle after 48 hours in proliferation.  At day 5 (72 hours 
after treatment) cells were dissociated and plated for differentiation as detailed in 
section of NPC differentiation.    
RNA Reverse transcription and Polymerase Chain Reaction analysis. Total mRNA 
was extracted from murine NPC and human NSC using TRIzol reagent (Sigma-
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Aldrich) followed by chloroform precipitation (Sigma-Aldrich). RNA was treated 
with RQ1 RNase-Free DNase (Promega, Milan, IT). cDNA was generated from 1 
μg of RNA by reverse transcription using ImProm-II Reverse Transcription System 
(Promega) according to manufacturer’s protocol. PCR reactions were performed 
using a GoTaq Flexi DNA polymerase kit (Promega) in a 25 μl mix containing (1 
μl of cDNA, Buffer 1x, 1.2 mM MgCl2, 0.6 mM dNTPs, and 0.5 μM of each 
primer). Primers for serotonin receptors: 5-HT2A, sense 5′-
ATAGCCGCTTCAACTCCAGA-3′, antisense 5′-ACGGCCATGATATTGGTGAT-
3’; 5-HT2C, sense 5′-TGATTGGACTGAGGGACGAAAGCA-3′, antisense 5′-
TTCCCACAAAGCACCGACAGGATA-3′; 5-HT7, sense 5'-
CTGGTGGTGGTTCTCAGTAGTATC-3', antisense 5'-
CAGCATAAGCAAAGTGGGGAGGTA-3'. Murine cDNA from adult 
hippocampal tissue was used as positive control.  
Mouse Hippocampal NPC differentiation. For NPC differentiation, single NPC 
cells were plated onto laminin-coated Lab-Tek 8-well permanox chamber slides 
(Nunc) in differentiation medium containing Neurobasal-A, B27 and 2 mM 
glutamine, at a density of 43,750 cells/cm2. NPC were treated with indicated drug 
concentrations or vehicle for 24h. To investigate the involvement of different 
serotoninergic and adrenergic receptors in antidepressants or serotonin effects, 
before addition of drugs, cells were first treated for 30 min with selective 
agonists/antagonists such as TCB-2 (5-HT2A agonist), WAY151606 (5-HT2c 
agonist), phenylephrine HCl (α1 AR agonist), NAD299 (5-HT1A antagonist), 
SB269970 (5-HT7 antagonist).  
Immunolocalization studies in differentiated murine NPC. Differentiated cells in 
chamber slides were fixed with 4% paraformaldehyde/4% saccharose solution 
(Sigma) for 20 min and processed for immunocytochemistry. After fixation cells 
were washed 3 times with saline phosphate buffer (PBS) and permealised in PBS 
containing 0.48% Triton X-100 (Sigma-Aldrich), 5 min at room temperature (RT). 
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Primary antibodies directed against: microtubule-associated protein-2 (MAP-2; 
rabbit polyclonal, 1:600; Millipore, Milan, IT), nestin (Chicken monoclonal, 
1:1500; Neuromics, DBA, IT), glial fibrillary acidic protein (GFAP, mouse 
polyclonal, 1:600, Millipore), SRY-related HMG-box gene (Sox-2, rabbit 
polyclona, 1:500 Millipore) were incubated for 150 min in humid chamber at RT. 
Secondary antibodies Alexa Fluor 555–conjugated goat anti-rabbit (1:1,400), Alexa 
Fluor 488-conjugated goat anti-chicken (1:1,400) (all from Molecular Probes, Life 
Technologies) were incubated for 50 min in humid chamber at RT . Nuclei were 
counterstained with 0.8ng/ml Hoechst (Thermo Fisher Scientific). In each 
experiment, five fields/well (corresponding to about 150-200 cells/well) were 
counted with a 60X objective by a Leica DMIRB inverted fluorescence 
microscope. Positive cells for each marker were counted and their percentage was 
calculated over total viable cells. Data are presented as percentage of increase over 
vehicle unless indicated otherwise. 
Statistical analysis. All experiments were run in triplicates using different cell 
preparations and repeated at least three times. Data were expressed as mean ± S.D. 
and analyzed using Student’s t-test when two independent groups were compared. 
One-way analysis of variance (ANOVA) followed by Tuckey’s post-Hoc test were 
performed to compare three or more groups. Statistical significance level was set 
for p values < 0.05. 
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Results  
Trazodone increases neuronal differentiation from ahNPC in a concentration 
and time dependent manner.  
Multipotent and proliferating ahNPC isolated from adult mouse hippocampi are 
cultured in vitro in presence of EGF and bFGF-2 as floating neurospheres. They 
are phenotypically characterized by the expression of SRY-related HMG-box gene 
2 (Sox-2) and nestin, markers of undifferentiated cells (Fig. 1 A) and by the 
absence of mature (MAP-2) and immature (class III beta-tubulin, Tuj-1) neuronal 
markers (Rietze and Reynolds, 2006; Meneghini et al., 2010). Upon removal of 
growth factors, ahNPC stop dividing and differentiate toward neuronal and 
astroglial lineages (Fig. 1 A). Cells cultured onto laminin-coated chamber slides for 
24 h in absence of EGF and FGF, were treated with a wide concentration range of 
trazodone (0.0003 - 100 μM). These cells were fixed and double labeled for MAP-
2 and nestin. We quantified neuronal differentiation by counting MAP-2+/nestin-
cells representing a more mature neuronal population and double MAP-2+/nestin+ 
cells representing an immature cell population of neuroblasts. Double negative 
MAP-2-/nestin- cells represented a heterogenous population including both glial-
committed and sox2+/nestin- undifferentiated progenitors. MAP2-/nestin+ cells 
represented the starting NPC population. As shown in Fig. 1 B, C in vitro 
trazodone promoted neurogenesis in a concentration dependent manner. We 
observed an increased percentage of MAP-2+/nestin- (ANOVA, p < 0.001) and 
MAP-2+/nestin+ cell population (ANOVA, p < 0.001) with maximal effect elicited 
by100 nM trazodone. Increased neuronal differentiation was paralleled with a 
decrease in non-neuronal MAP-2-/nestin- cells (ANOVA, p< 0.001, Fig. 1 D). We 
did not observe any significant difference in the apoptotic rate of trazodone-treated 
cells at any concentration compared to vehicle-treated cells (Fig. 1 E).  
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At each time point cells were fixed and double stained for MAP-2 and nestin and 
counted. Results in Fig. 2 A, B showed that at 12 h trazodone increased 
significantly the percentage of immature MAP-2+/nestin+ cells (Tukey post hoc, p < 
0.01), while 5-HT increased significantly the percentage of both MAP-2+/nestin- 
(Tukey, p < 0.01) and MAP-2+/nestin+ cells (Tukey, p < 0.05). In contrast VEN did 
not have a significant effect on neuronal differentiation at 12 h. At 24 h trazodone, 
5-HT and VEN increased significantly the percentage of MAP-2+/nestin- (ANOVA, 
p< 0.001) and immature MAP-2+/nestin+ cells (ANOVA, p< 0.001). Interestingly at 
48 h only trazodone maintained a proneurogenic effect on MAP-2+/nestin- cells 
(Tukey post-hoc, p<0.001). We observed a parallel significant decrease in non-
neuronal MAP-2-/nestin- population in all treatments at 12 h (ANOVA, p < 0.01) 
and 24 h (ANOVA, p < 0.01) whereas this decrease was observed only in 
trazodone at 48 h (Tukey, p < 0.001) (Fig. 2 C). Neither trazodone nor 5-HT and 
VEN had a significant effect on the apoptotic rate within the same time point (Fig. 
2 D). In summary, trazodone is proneurogenic in the in vitro model of ahNPC in a 
concentration and time-dependent manner. When compared to 5-HT and VEN, 
only trazodone increased the number of mature neurons after 48 h.  
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Figure 1: Trazodone effect on neuronal differentiation of adult hippocampal neural progenitor cells 
(ahNPC) in vitro. (A) Fluorescent confocal microscope images of adult hippocampal NPC neurospheres 
immunolabeled for Sox-2 and nestin, markers of undifferentiated cells. In absence of growth factors ahNPC 
differentiate toward neuronal (MAP-2, red) and astroglial (GFAP, green) cells. Nuclear staining: Hoechst. 
Magnifications 400X. Scale bar = 10 μm. (B-C-D-E) ahNPC were differentiated for 24 h in presence of 
trazodone (TZD, 0.0001 – 100 μM) and corresponding vehicle. Then cells were fixed and double stained for 
MAP-2 (neurons marker) and nestin. Cells were counted/quantified under fluorescent microscope and 
categorized as: MAP-2+/nestin-, MAP-2+/nestin+, MAP-2-/nestin- and apoptotic cells. Data are expressed as 
percentage of increase over vehicle-treated cells ± SD of experiments performed in triplicate. Statistical 
analysis was performed by one-way repeated measure ANOVA followed by Tukey’s post hoc multiple 
comparisons test. *P < 0.05, **P < 0.01, ***P < 0.001.  
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5-HT2A/2C receptors are expressed by hippocampal neural progenitor cells and 
their antagonism mediates trazodone proneurogenic effect. 
In order to determine the contribution of distinct receptors in the proneurogenic 
effect of trazodone we treated ahNPC with trazodone and/or specific receptor 
agonist/antagonists. Since transcripts for 5-HT1A are also expressed by the in vitro 
model of ahNPC (Benninghoff et al., 2010), we investigated whether the effect of 
trazodone on neuronal differentiation is dependent on its agonistic activity on 5-
HT1A. For that target we exposed ahNPC to trazodone (100 nM) in presence of 
NAD299 (30 nM), a selective 5-HT1A antagonist [Ki (5-HT1A) = 0.6 nM] or its 
corresponding vehicle for 24h. As shown in Fig. 3 A, B NAD299 did not block 
trazodone proneurogenic effect neither on MAP-2+/nestin- (Tukey, p < 0.001) nor 
on immature MAP-2+/nestin+ cells (Tukey, p < 0.001). The increase in neuronal 
Figure 2: Time course assessment of trazodone proneurogenic effect compared to serotonin and 
venlafaxine. Cells were differentiated for 2, 12, 24 and 48 h in presence of vehicle, trazodone (TZD, 100 nM), 
serotonin (5-HT, 1 μM) and venlafaxine (VEN, 10 μM) then fixed and stained for MAP-2 and nestin. We 
show MAP-2+/nestin- and MAP-2+/nestin+, MAP-2-/nestin- and apoptotic cells quantification. Data 
are expressed as percentage of increase over vehicle-treated cells ± SD of experiments performed in triplicate. 
Statistical analysis was performed by one-way repeated measure ANOVA followed by Tukey’s post hoc 
multiple comparisons test vs. vehicle of the same time point. *P < 0.05, **P < 0.01, ***P < 0.001.  
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differentiation by trazodone was paralleled by a decrease in MAP-2-/nestin- cells 
(Tukey, p < 0.001) (data not shown). Exposing cells to NAD 299 by itself or in 
presence of trazodone did not affect the apoptotic rate of ahNPC and their progeny 
(Fig. 3 C). 
We evaluated the expression of 5-HT2A and 5-HT2C serotonin receptors in 
proliferative ahNPC by (RT)-PCR analysis. Results showed that ahNPC express 
mRNA for 5-HT2A and 5-HT2C serotonin receptors (Fig. 3 D). We studied the 
involvement of 5-HT2 in trazodone proneurogenic effect on WT ahNPC. For that 
purpose, we treated ahNPC with proneurogenic trazodone concentrations (30, 100 
and 300 nM) in presence of TCB-2 (10 nM), a 5-HT2A high affinity agonist [Ki (5-
HT2A) = 0.73 nM], or WAY151603 (WAY, 10 nM), a potent and selective 5-HT2C 
agonist [Ki (5-HT2C) = 4 nM]. (Fig. 3 E, F). The agonists by themselves, compared to 
vehicle, did not have a significant effect on neuronal differentiation (Fig. 3 E, F) or 
on the apoptotic rate (data not shown). As expected, trazodone 30, 100 and 300 nM 
concentrations were proneurogenic as proven by increased percentage of MAP-
2+/nestin- (ANOVA, p < 0.001) and MAP-2+/nestin+ (ANOVA, p < 0.001) cells. 
Interestingly, both WAY and TCB-2 shifted trazodone response curve to the right 
(Tukey, p< 0.001) (Fig. 3, E, F). Overall these results suggest that trazodone 
binding to serotonin receptors 5-HT2A/2C but not 5-HT1A mediated its 
proneurogenic effects.  
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Figure 3: Involvement of serotonin receptors 5-HT1A, 5-HT2A and 5-HT2C in trazodone proneurogenic 
effect on ahNPC. (A-C) ahNPC in differentiation were treated for 24 h with trazodone (TZD, 100 nM) in 
presence of 5-HT1A antagonist NAD299 (30 nM). We show MAP-2+/nestin- and MAP-2+/nestin+ and 
apoptotic cells quantification. (D) Representative images of (RT)-PCR analysis for the expression of 5-
HT2A (493bp), 5-HT2C (445bp) receptors (RT+). Positive control for mRNA expression was cDNA from adult 
hippocampus tissue (HP RT+). Negative reverse transcription reactions (RT) for ahNPC were used as negative 
control (RT-). The 100-base pair (bp) DNA ladder was used as molecular weight (mw) marker. (E-F) ahNPC 
in differentiation were treated for 24 h with trazodone (30, 100 and 300 nM) in presence or absence of 
WAY151603 (5-HT2C agonist, 10 nM) or TCB-2 (5-HT2A agonist, 10 nM). We show MAP-2+/nestin- and 
MAP-2+/nestin+ quantification. Data are expressed as percentage of increase over vehicle-treated cells ± 
SD of experiments performed in triplicate. Statistical analysis was performed by one-way repeated measure 
ANOVA followed by Tukey’s post hoc multiple comparison tests. ***P < 0.001. NAD299 “NAD”; 
WAY151603 “WAY”. 
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Trazodone effect on neuronal differentiation does not require its binding to α1 
and α2 adrenergic receptors. 
Since trazodone is also an antagonist of α1 and α2 AR we investigated if this 
activity could mediate its proneurogenic effect. We treated ahNPC with trazodone 
in presence of L-phenylephrine, an α1 AR agonist [Ki (α1a) = 4.7 nM] (PHE). As 
shown in Fig. 4 A, B L-phenylephrine did not counteract the proneurogenic effect 
of trazodone on MAP-2+/nestin- cells (ANOVA, p < 0.0001) and MAP-2+/nestin+ 
neuroblasts (ANOVA, p < 0.0001) at any tested concentration. We also treated 
cells with idazoxan, an α2 AR antagonist [Ki (α2a) = 8.01 nM]. We did not observe 
any effect on neuronal differentiation compared to vehicle (Fig. 4 C, D). In 
summary, these results showed that adrenergic receptors do not mediate the 
proneurogenic effect of trazodone. 
Serotonin depletion in ahNPC inhibits the proneurogenic effect of trazodone 
but not 5-HT and venlafaxine. 
Serotonin could be synthetized by ahNPC through the enzyme TPH2 (Benninghoff 
et al., 2010). Since we observed that trazodone antagonistic activity on 5-HT2A/2C 
mediate its proneurogenic effects, we hypothesized the presence of an endogenous 
serotoninergic tone. We decided to deplete serotonin in ahNPC and evaluate its 
effect on ahNPC under basal and drug-treated conditions. To deplete 5-HT we 
treated ahNPC for 72 h with TPH2 irreversible inhibitor PCPA (50 μM) or vehicle. 
PCPA-treated and vehicle-treated neurospheres were dissociated and plated at the 
same density for differentiation in absence of growth factors (Fig. 5 A, 
experimental timeline). Cells were differentiated with proneurogenic 
concentrations of trazodone (30, 100 and 300 nM), 5-HT (1 μM), VEN (10 μM) or 
vehicle for 24 h. As expected, trazodone, 5-HT and VEN increased the percentage 
of both neuronal populations from vehicle-treated cells (ANOVA, p< 0.001, Tukey 
post hoc test, p < 0.001, Fig. 5 B, C). We observed that PCPA-treated ahNPC gave 
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Figure 4: Involvement of adrenergic receptors α1 and α2 in trazodone proneurogenic effect on ahNPC. 
A-B- Cells were differentiated for 24 h with trazodone (TZD, 30-100 and 300 nM) in presence or absence of 
L-phenylephrine (α1 agonist, 30 or 100 μM) or (C-D) idazoxan (α2 antagonist, 0.001 - 1 μM). We show 
MAP-2+/nestin- and MAP-2+/nestin+ quantification. Data are expressed as percentage over vehicle-treated 
cells ± SD of experiments performed in triplicate. Statistical analysis was performed by one-way repeated 
measure ANOVA followed by Tukey’s post hoc multiple comparison tests. ***P < 0.001. L-phenylephrine 
“PHE”; Idazoxan “IDZ” 
rise to a lower percentage of MAP-2+/nestin- compared to vehicle-treated (Tukey 
post hoc test, PCPA vs. vehicle treated cells, p < 0.05) while the percentage of 
immature MAP-2+/Nestin+ cells was not affected (Fig.5 B, C). 
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Trazodone proneurogenic effect was inhibited totally in PCPA-treated cells, while 
5-HT and VEN produced a significant increase of MAP-2+/nestin- (ANOVA, p < 
0.001, Tukey post hoc test, p < 0.01) and immature MAP-2+/Nestin+ (ANOVA, p < 
0.001, Tukey post hoc test, p < 0.001) cells (Fig.5 B, C). The lack of response to 
trazodone by PCPA-treated cells could not be due to increased apoptotic rate since 
we did not observe significant differences between vehicle-treated and PCPA-
treated ahNPC (Fig. 5 D). Altogether these results further confirmed that trazodone 
proneurogenic effects were due to its antagonistic activity on 5-HT2A/2C receptors.  
The NF-𝜅B p50 signaling pathway is potential player in trazodone effect. 
Since NF-𝜅B transcription factors and in particular p50 mediate the proneurogenic 
response to several drugs (Valente et al., 2012; Meneghini et al., 2013), we asked 
whether trazodone proneurogenic activity is also regulated by NF-𝜅B signaling.  
We prepared ahNPC from wild type (WT) and p50KO mice. In differentiating 
conditions WT and p50KO ahNPC were treated with trazodone (100 nM), 5-HT (1 
μM) and VEN (10 μM). As expected, trazodone, 5-HT and VEN increased 
significantly MAP-2+/nestin- (ANOVA, p < 0.001) and MAP-2+/Nestin+ (ANOVA, 
p < 0.001) cells generated by WT ahNPC. Remarkably p50KO ahNPC did not 
respond to proneurogenic effect of trazodone while 5-HT (Tukey, p < 0.001) and 
VEN (Tukey, p < 0.001) increased significantly both MAP-2+/nestin- and MAP-
2+/Nestin+ cells (Fig. 6, A, B). The significant increase in neuronal population was 
paralleled by a significant decrease in non-neuronal MAP-2-/Nestin- (ANOVA, p < 
0.001) cells (Fig. 6, C). We did not observe significant differences in the apoptotic 
rate of WT and p50KO ahNPC under basal and drug treatment conditions (Fig. 6, 
D). Together these results show that trazodone proneurogenic effect depend on the 
presence of NF-𝜅B p50 subunit in ahNPC.  
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Figure 5: The effect of serotonin depletion on ahNPC differentiation and trazodone 
proneurogenic effect. (A) Experimental time line. (B-C-D) ahNPC in proliferation were treated 
with PCPA (50) for 72 h then differentiated in presence of trazodone (TZD, 30-100 and 300 nM), 
serotonin (5-HT, 1 μM) and venlafaxine (VEN, 10 μM). Vehicle treated cells (light grey bars) 
and PCPA-Treated cells (dark grey bars). We show MAP-2+/nestin- and MAP-2+/nestin+ and 
apoptotic cells quantification. Data are expressed as percentage over viable cells ± SD and over 
total cells for the apoptotic rate. Experiments were run in triplicate. Statistical analysis was 
performed by one-way repeated measure ANOVA followed by Tukey’s post hoc multiple 
comparison tests. ***P < 0.001 vs. vehicle-treated cells. $$P < 0.01, $$$P < 0.001 vs. PCPA-
treated cells. #p < 0.05, vehicle- vs. PCPA-treated cells. DL-P-chlorophenylalanine, PCPA. 
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5-HT proneurogenic effect is mediated by 5-HT7 receptors.  
Altogether our data suggested that trazodone and 5-HT induce neurogenesis in 
vitro via distinct mechanisms. For this reason, we characterized which serotonin 
receptors mediate in vitro the proneurogenic effect of the endogenous 
neurotransmitter. First, we studied a possible role of 5-HT1A. We tested the effect 
of a wide range of 5-HT concentrations (0.0001 – 100 μM) in presence or absence 
of NAD299 (10 nM). Results in Fig. 7 A, B showed that 5-HT concentrations 
(0.001 – 10 μM) increase both MAP-2+/nestin- (ANOVA, p < 0.001) and MAP-
2+/nestin+ cells (data not shown). NAD299 by itself did not affect neurogenesis and 
did not inhibit the proneurogenic effect of 5-HT.  
Figure 6: The role of NF-𝜅B p50 signaling pathway in mediating the increase of neuronal 
differentiation by trazodone. ahNPC from WT and NF-𝜅B p50 KO mice were isolated for 
culture in vitro in proliferation. Both genotypes were differentiated in presence of (A-B) Trazodone 
(TZD, 100 nM), 5-HT (1 μM) and VEN (10 μM). We show MAP-2+/nestin- and MAP-2+/nestin+, 
MAP-2-/nestin- and apoptotic cells quantification. Data are expressed as percentage of increase 
over vehicle-treated cells ± SD of experiments performed in triplicate. Statistical analysis was 
performed by one-way repeated measure ANOVA followed by Tukey’s post hoc multiple 
comparison tests. ***P < 0.001. NF-𝜅B p50 Knock out ahNPC “KO”. 
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Last but not least we could demonstrate by (RT)-PCR analysis that ahNPC express 
mRNA specific for 5-HT7 receptor (Fig. 7, B). To assess the potential contribution 
of 5-HT7 in serotonin effect, we treated ahNPC with 5-HT (1 μM) in presence or 
absence of SB269970 (SB), a 5-HT7 antagonist [Ki (5-HT7) = 8.9 nM]. As shown in 
Fig. 7 C, 5-HT (Tukey, p< 0.001) increased significantly the percentage of MAP-
2+/nestin- cells. SB per se did not affect the neuronal differentiation of ahNPC. SB 
1, 10 and 100 nM counteracted the proneurogenic effect of 5-HT. Altogether these 
data showed that 5-HT7 but not 5-HT1A might be involved in 5-HT proneurogenic 
effect on ahNPC in vitro model.  
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Figure 7: Serotonin receptors 5-HT1A and 5-HT7 involvement in 5-HT proneurogenic effect. (A) 
ahNPC were treated with a wide range of 5-HT (0.0001 – 100 μM) in presence or absence of NAD299 (5-
HT1A antagonist, 10 nM). (B) Representative images of (RT)-PCR analysis showing the expression of 5-HT7 
(852bp) in WT proliferative ahNPC (RT+). Positive control for mRNA expression was cDNA from adult 
hippocampus tissue (HP RT+). Negative reverse transcription reactions (RT) for ahNPC were used as 
negative control (RT-). The 100 bp DNA ladder was used as molecular weight (mw) marker. (C) ahNPC 
were differentiated for 24 h in presence of 5-HT (1 μM) in presence of SB269970 (5-HT7 antagonist) 
concentrations (1- 10 - 100 nM). We show MAP-2+/nestin- cells quantification. Data are expressed as 
percentage of increase over vehicle-treated cells ± SD of experiments performed in triplicate. Statistical 
analysis was performed by one-way repeated measure ANOVA followed by Tukey’s post hoc multiple 
comparison tests. **P < 0.01, ***P < 0.001. 
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Discussion 
The generation of new neurons during post-natal and adult life is a highly plastic 
process regulated by exercise, learning, stress and markedly downregulated in 
neuropsychiatric disorder specifically in MDD (Kempermann et al., 2008; Aimone 
et al., 2014). Interestingly adult hippocampal neurogenesis is necessary for the 
therapeutic effect of several antidepressants in rodents, non-human primates and 
human mammalian brain (Santarelli et al, 2003; Malberg et al., 2000; Boldrini et al, 
2009). Evidence correlating antidepressants to increased adult hippocampal 
neurogenesis support the possibility that such effect participates to the therapeutic 
effect of these drugs. Trazodone is a 5-HT2 antagonist, SERT inhibitor and 5-HT1A 
partial agonist antidepressant, with unknown effect on adult neurogenesis. In our 
study, we used an in vitro model of adult hippocampus derived NPC culture to test 
the effect of trazodone on neuronal differentiation. In such model, we showed, for 
the first time, that trazodone increased the percentage of both more mature and 
immature neuroblasts in a concentration and time dependent manner. In the time 
course assay, we also treated cells with 5-HT and venlafaxine (VEN) as reference 
compounds for trazodone effect.  
The endogenous neurotransmitter 5-HT is the physiological agonist of all serotonin 
receptors and is known to increase the proliferation and maturation of ahNPC 
mainly through 5-HT1A receptor (Alenina and Klempin, 2015). VEN is an SNRI 
antidepressant that increases the number and long term viability of proliferative 
NPC and mature neuron (NeuN+) in the SGZ of rats (Khawaja et al., 2004; Xu et 
al., 2006; Asokan et al., 2014). We confirmed in vitro that trazodone, 5-HT and 
VEN increase neuronal differentiation from ahNPC. Moreover, we observed that 
only trazodone, and not 5-HT nor VEN, maintained a significant increase on 
mature neurons after 48h. We could not report any effect by trazodone and 
reference compounds on the survival of ahNPC and their progeny. Therefore, we 
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suggest that the effect of trazodone in our settings is exclusive on ahNPC 
differentiation and not survival.  
We then determined the receptors involved in trazodone proneurogenic effect. We 
confirmed by qualitative PCR analysis that ahNPCs express 5-HT2A, 5-HT2C and 5-
HT1A receptors (data not shown). Previous reports showed that hippocampal NPC 
in vivo and in vitro express 5-HT2B, 5-HT2C, 5-HT1A as well as the 5-HT producing 
enzyme TPH2 (Benninghoff et al., 2010; Brichta et al., 2013). We investigated 
whether 5-HT1A receptors mediate the proneurogenic effect of trazodone on 
ahNPC. Results showed that a 5-HT1A antagonist (NAD299) per se did not affect 
neuronal differentiation and did not inhibit the proneurogenic effect of trazodone at 
any concentration, without affecting the apoptotic rate. Literature data suggest that 
5-HT1A is involved in NPC proliferation but not in neuronal differentiation. Earlier 
studies reported that 5-HT1A antagonist caused a 30% reduction of proliferative 
ahNPC in vivo (Radley and Jacobs 2002). Moreover, serotonin depletion by DL-P-
chlorophenylalanine (PCPA), an irreversible inhibitor of TPH2, followed by 
treatment with postsynaptic 5-HT1A agonist (8-OH-DPAT) rescued the number of 
proliferative ahNPC BrdU+ in the SGZ (Banasr et al, 2003). In vitro PCPA 
treatment and 5-HT1A antagonist hampered the proliferation but not the 
differentiation of ahNPC. Finally, proliferation was rescued by 5-HT or 5-HT1A 
agonist treatment (Benninghoff et al., 2010).  
We studied the possible involvement of 5-HT2 receptors in trazodone effect. 5-
HT2A agonist (WAY151603) or 5-HT2C agonist (TCB-2) per se did not produce 
any effect on neuronal differentiation of ahNPC (Fig. 3 E,F). We then tested their 
effect in presence of trazodone. Pretreatment of cells with 5-HT2A agonist 
(WAY151603) or 5-HT2C agonist (TCB-2) occupy 5-HT2 receptors and prevent the 
binding of trazodone. Results showed that 5-HT2C and 5-HT2A agonists inhibited 
the effect of trazodone in a concentration-dependent fashion. These observations 
further support the idea that both receptors mediate trazodone proneurogenic effect. 
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In vivo studies showed that 5-HT2C antagonist restored the levels of BDNF, a 
positive modulator of neurogenesis, followed by an increased number of 
proliferative cells (BrdU+) in mice SGZ. Vice versa the activation of 5-HT2C in vivo 
decreased mRNA and protein levels of BDNF (Vaidya et al., 1997, Klempin et al. 
2010). Agomelatine, a melatonergic receptor (M1 and M2) agonist and 5-HT2C 
antagonist antidepressant, in vivo increases ahNPC proliferation in the SGZ (BrdU 
labeling) and stimulates BDNF signaling pathway in adult rat hippocampus. This 
effect appears to be due to both melatonergic agonistic activity and 5-HT2 
antagonism (Soumier et al., 2009). Controversial results reported that ketanserin (5-
HT2A/2C antagonist) produced a decrease in the number of BrdU-labeled cells 
whereas DOI (5-HT2A/2C agonist) treatment did not change cells proliferation 
(Banasr et al, 2003). Based on our as well as literature data, we can postulate that 
5-HT2A/2C antagonism could have a significant role in neuronal differentiation of 
ahNPC. Trazodone can also bind α1/α2 AR and H1 receptors. We showed in this 
study that trazodone proneurogenic effect does not involve α1 and α2 AR. 
Moreover, we could also exclude a contribution of H1 receptors in its effect (data 
not shown). 
Irreversible inhibition of TPH2 by PCPA decreases the proliferation of murine 
ahNPC without affecting their basal neuronal differentiation; moreover, 
exogenously added 5-HT can restore proliferation rate under the same experimental 
conditions (Benninghoff et al., 2010). Since we observed that trazodone 
proneurogenic effect was mediated by 5-HT2A/2C antagonism, we then evaluated the 
effect of the drug in PCPA-treated ahNPC. In these conditions the proneurogenic 
effect of trazodone was abolished, further supporting the idea that the antagonistic 
activity of trazodone on 5-HT2A/2C was mediating its activity. In the same 
experimental setting, 5-HT and venlafaxine were still proneurogenic. The 
proneurogenic effect of the endogenous agonist suggests that serotonin receptors 
expression is likely not affected by TPH2 irreversible inhibition. Venlafaxine 
CHAPTER IV 
145 
 
proneurogenic effect in PCPA-treated cells also confirms that ahNPC are still 
responsive to antidepressants with a different (noradrenergic) mechanism of action. 
Altogether we may conclude that trazodone proneurogenic effect is indeed 5-
HT2A/2C antagonism dependent. Interestingly, we also observed a small but 
significant reduction in differentiation toward more mature neuronal cells (stained 
MAP-2+/nestin- cells) but not toward immature neuroblasts from PCPA-treated 
compared to vehicle-treated cells. We doubt that these observations could be due 
apoptosis of that specific cell population, since we did not observe significant 
differences in the apoptotic rate of ahNPC and their progeny in that experimental 
condition. Our results are in line with Benninghoff et al. (2010) who did not 
observe a difference in Tuj-1 (another marker of neuroblasts) expressing cells after 
PCPA-treatment. One possible explanation is that serotonin depletion may 
specifically affect later neuronal maturation of newly generated cells. Additionally, 
several in vivo studies showed that 5-HT depletion in the brain does not cause a 
dramatic reduction of neurogenesis but inhibits the response to positive modulators 
such as running, enriched environment, learning and antidepressants (Klempin et 
al., 2013, Alenina and klempin, 2015).  
Our group previously reported that the inhibition of NF-κB activation counteract 
the proneurogenic effect of clinically relevant drugs such as 2 ligands and 
acetyl-L-carnitine, all characterized by antidepressant activity in murine models of 
unpredictable mild stress (Cuccurazzu et al., 2013; Meneghini et al. 2014). We 
therefore tested trazodone on ahNPC deriving from NF-κB p50 knock out mice. In 
contrast to 5-HT and venlafaxine, trazodone proneurogenic effect appeared to 
require the presence of NF-κB p50.  
In this study, we also further explored the receptor subtype(s) mediating 5-HT 
proneurogenic effect. Based on literature reports, we initially took into 
consideration an involvement of 5-HT1A receptors (Banerjee et al., 2007; Kaufman 
et al., 2016). To our surprise a 5-HT1A antagonist did not counteract the in vitro 
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proneurogenic effect of 5-HT. The 5-HT7 receptors are the latest addition to 5-HT 
receptors family and are characterized for their high affinity to 5-HT (Sleight et al., 
1995). 5-HT7 receptor binds with high affinity the antidepressant amitriptyline 
(Mullins et al., 1999). Moreover, chronic antidepressant treatment downregulates 
5-HT7 receptors expression in rat hypothalamus (Guscott et al., 2005). We tested 
the potential involvement of 5-HT7 in mediating 5-HT proneurogenic effect in 
vitro. We evaluated the effect of the 5-HT7 antagonist SB269970 alone and in 
presence of 5-HT on ahNPC. SB269970 per se did not affect neuronal 
differentiation but it inhibited the proneurogenic effect of 5-HT. Thus, at least in 
part, serotonin might increase neuronal differentiation of ahNPC through 5-HT7 
activation. The involvement of 5-HT7 in mediating antidepressant activity is still 
controversial and will certainly require further investigation in vitro and in vivo 
(Nandam et al., 2007). 
In summary, our results indicated that trazodone is a proneurogenic antidepressant 
and that at least in vitro, this activity is mediated by 5-HT2A/2C antagonism. 
Moreover NF-κB p50 subunit is required for trazodone, but not serotonin, 
proneurogenic activity. Finally, for the first time, we propose the involvement of 5-
HT7 receptors in the in vitro regulation of adult hippocampal neurogenesis. 
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Discussion and conclusions 
The initial work of the scientist “Santiago Ramón y Cajal” showed that neurons do 
not proliferate and are not replaced in adult life. For long times scientists were 
convinced that we are born with the neurons that we will ever have. Indeed, the 
adult generation of new neurons in the brain was a taboo until the 60’s when 
scientists showed that: (i) radioactive thymidine was detected in the adult brain (ii) 
proliferative cells could differentiate toward neurons and (iii) proliferative cells can 
be isolated from adult brain and culture in vitro (Reynolds and Weiss, 1992). Since 
the beginning of the 80’s decades of studies investigated the nature, the zones and 
the role of adult neurogenesis. A great interest was given to adult neurogenesis in 
the hippocampus since it is the main center of cognitive functions like learning and 
memory (Bannerman et al., 2004). Several neurodegenerative and neuropsychiatric 
disorders that are characterized by loss of cognitive functions were also described 
for a reduced ahNG and altered astrocytes function (Kempermann and Kronenberg, 
2003; Pekny et al., 2016). 
My PhD work, embedded in the general topic of ahNG studies, focused on 
studying the effect of potential endogenous neuro-modulatory proteins secreted by 
local astrocytes and exogenous pharmacological compounds on ahNPC neuronal 
differentiation by in vitro approaches. We studied the role of NF-κB transcription 
factors, specially the NF-κB p50 subunit, as downstream signaling required for 
effective proneurogenic activity.  
We gave a particular attention to the astrocytes-ahNPC cross-talk based on 
literature observations and earlier studies performed in our lab. Our group observed 
that in vivo p50KO ahNPC have defective late neuronal differentiation and p50 KO 
mice have impaired hippocampal-dependent spatial memory (Denis-Donini et al., 
2008). In contrast, in vitro, spontaneous differentiation of p50KO ahNPC, was not 
different from their WT counterpart. An elegant earlier work done by Song and 
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colleagues (2002), showed that astrocytes and NPC co-culture increased the 
neuronal differentiation from the NPC. Moreover, this increase was region-specific 
since hippocampal but not spinal cord-derived astrocytes increased the neuronal 
differentiation from hippocampal NPC (Song et al., 2002). The mechanisms 
employed by astrocytes are still poorly understood and little is known about the 
identity of astrocytes-secreted proteins and their effect on ahNPC neuronal 
differentiation. The hypothesis of our work stated that possibly astrocytes signaling 
and protein secretion is altered in absence of NF-κB p50 explaining altered ahNG 
observed in vivo. Our aim during PhD years was to understand (i) how astrocytes 
communicate with ahNPC, (ii) determine proteins and receptors involved in this 
regulation and (iii) study possible defects caused by NF-κB p50 depletion in both 
astrocytes and ahNPC. Results by LC-MS/MS analysis identified proteins 
differentially expressed in WT and p50KO astrocytes conditioned media. We found 
three proteins upregulated in p50KO compared to WT astrocytes conditioned 
media. Two of these proteins are encoded by NF-B target genes and NF-κB 
signaling activation. Thus we could show that astrocytes express and release 
soluble factors in the medium. Moreover we showed that p50KO ahNPC have 
reduced response to astrocyte-derived pro-neurogenic signals such as 
thrombospondin- 1 (molecule already known as proneurogenic) and Lipocalin- 2 
(characterized for the first time in our study as proneurogenic molecule). In attempt 
to explain this lack of response we found that in fact the absence of p50 caused a 
downregulation in α2δ1 subunit (thrombospondin receptor) and LCN-2R/24p3R 
(lipocalin receptor) expression in p50KO ahNPC compared to WT. Therefore, 
ahNPC express receptors for astrocytes released factors an respond in changing 
their differentiation. Ultimately, the outcome of this study showed that the absence 
of NF-κB p50 subunit cause complex cell autonomous and non-cell autonomous 
defects in the astrocytes-ahNPC cross-talk. These findings could explain reduced 
ahNG and memory defects observed in vivo. Altogether, these data add further 
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complexity to the relevance of astrocytes and NF-B signaling in the modulation of 
adult neurogenesis. Moreover, it suggests new proteins and mechanisms employed 
by astrocytes to regulate ahNPC neuronal differentiation. 
Our laboratory also participated for many years in studying ahNG in vivo and in 
vitro for its response to drugs with antidepressants-like effect and the role of NF-
B signaling in mediating their proneurogenic effect. This work is based on several 
studies showing that both acute and chronic stress reduce ahNPC proliferation and 
differentiation in the SGZ (Pittenger and Duman, 2007). Studies on rodents, non-
human primates and human mammalian brain showed that ahNG is decreased in 
depression disorder and increased after antidepressant treatment (Santarelli et al, 
2003; Malberg et al., 2000; Boldrini et al, 2009). Recently the neurogenic 
hypothesis of depression states that “the production of new granule cells in the 
dentate gyrus of the hippocampus is linked to the pathophysiology of depression 
and that the increase in hippocampal neurogenesis and plasticity are required for 
the behavioral effect of antidepressant treatment” (Eisch and Petrick, 2012).   
Antidepressants such as TCA, SSRI and SNRI increase the levels of monoamines 
neurotransmitters in the synaptic cleft, thus alleviating the depressive symptoms. 
These antidepressants were not selective only on the serotoninergic or 
noradrenergic receptors but had also dopaminergic and cholinergic activity 
underlying their several side effects (Lopez-Munoz and Alamo, 2009). Even 
though the neurochemical effect of these antidepressants was fast the therapeutic 
activity onset took 3 to 4 weeks (Pittenger and Duman, 2008). Altogether these 
reasons caused that more than 50% of patients quit therapy (Berton and Nestler, 
2006). Molecular studies allowed us to understand that 5-HT have several receptors 
types with different and even opposite roles. Despite these findings, the effect of 
antidepressants is still poorly studied with regard to its specificity to distinct 
serotonin receptors. Based on this gap of knowledge we chose Trazodone. It is a 
serotonin antagonist and reuptake inhibitor antidepressant (SARI) (Stahl, 2009). 
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The choice of trazodone was based on its peculiar distinct activity on serotonin 
receptors. It is an antagonist of 5-HT2A/2C serotonin receptors. 5-HT2 activation 
mediates the side effects of antidepressants such as anxiety and sleeplessness. 
Therefore, beside antidepressant, trazodone is commonly prescribed as a hypnotic 
and anxiolytic drug. Moreover, trazodone is 5-HT1A partial agonist, the mechanism 
by which 5-HT induce the antidepressant (Chilmonczyk et al., 2015). Last but not 
least, trazodone is also a dose-dependent antagonist for α1 and α2 adrenergic 
receptors and histamine receptor H1. Trazodone interestingly has a negligible 
anticholinergic activity usually causing tremors as side effects in antidepressant 
treatment. Taking into consideration the knowledge about trazodone therapeutic 
effect and its mechanism of action, we suggested that its multimodal activity that is 
the asset of its antidepressant activity, could also modulate ahNG. Our study is the 
first to show that trazodone is proneurogenic in a concentration and time-dependent 
manner. Trazodone did not influence apoptosis even at high concentrations thus 
trazodone it is has also a safe profile with regard to cytotoxicity. We also observed 
that trazodone, compared to 5-HT and venlafaxine (SNRI), was the only drug that 
increased the percentage of mature neurons after 48 h of treatment. Therefore, 
trazodone might have an additive effect on late neuronal maturation. Interestingly, 
late maturation phase is one of the most critical phases of neuronal differentiation 
since it determines the integration of young neurons in the network activity (Ge et 
al, 2007). When we studied the involvement of different receptors in trazodone 
effect we showed that 5-HT2A and 5-HT2C antagonistic activity mediated the 
increase in neuronal differentiation. We also found that neither 5-HT1A nor α1 and 
α2 adrenergic receptors were involved in trazodone effect. Literature studies 
reported that 5-HT1A activation increase ahNPC proliferation (Vaidya et al., 1997, 
Klempin et al. 2010) whereas the effects of 5-HT2 activation or blockade on ahNG 
are still controversial. Our results also showed that 5-HT2A/2C agonists did not 
influence differentiation but they blocked trazodone effect. Altogether we suggest 
that 5-HT1A activation could be involved in ahNPC proliferation whereas 5-HT2A/2C 
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inhibition could be involved in neuronal differentiation. These observations add 
more insight into the diversity of serotonin receptors activity on ahNG and the 
importance of multimodal antidepressants. Moreover, for the first time we 
suggested that 5-HT2A/2C antagonism has a positive effect on neuronal 
differentiation. 
Recent studies showed that ahNPC in fact may secrete serotonin since they express 
the TPH2 (5-HT synthesis enzyme in neurons). Trazodone proneurogenic effect 
was completely inhibited in TPH2 depleted cells while 5-HT and venlafaxine 
maintained their effect. By that we confirmed that in absence of the endogenous 
serotoninergic tone, trazodone antagonistic activity on 5-HT2A/2C does not produce 
a proneurogenic effect. Serotonin depletion downregulates ahNPC proliferation but 
does not affect the generation of Tuj-1 (immature neurons marker) marked cells 
(Benninghoff et al., 2010). When we depleted serotonin in our cells we also 
confirmed that the number of immature neurons was not different compared to non-
depleted cells. But interestingly the mature neurons number was significantly less 
in serotonin-depleted cells compared to vehicle. This important observation in vitro 
is consistent with in vivo studies showing that the absence of 5-HT counteracts the 
effect of positive modulators of ahNG on differentiation and specifically the 
maturation of ahNPC (Klempin et al., 2013). 
To study downstream signaling potentially involved in trazodone signaling we 
suggested the involvement of NF-κB transcription factors specifically the p50 
subunit. Our idea was based on previous studies in our lab and other groups 
showing that NF-κB transcription factors are expressed in the neurogenic niches 
and might be involved in ahNG (Denis-Donini et al., 2005; Valente et al., 2012; 
Cuccurazzu et al., 2013). We showed that p50KO ahNPC do not respond to 
trazodone proneurogenic activity. An interesting observation was also that 5-HT 
and venlafaxine effect was not counteracted by the absence of NF-κB p50. Thus, 
we suggested that trazodone effect require the presence of NF-κB p50 subunit 
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while 5-HT do not. It would be of interest to further investigate downstream gene 
expression modifications mediated by trazodone. Taking into consideration the 
differences we observed between 5-HT and trazodone in absence of NF-κB p50 we 
hypothesized that different receptor subtypes mediate 5-HT proneurogenic effect. 
We showed that 5-HT7 and not 5-HT1A mediate at least in part the proneurogenic 
effect of 5-HT in vitro. 5-HT7 has high affinity to 5-HT and it is possibly involved 
in antidepressant activity. We could suggest for the first time possible involvement 
of 5-HT7 in ahNG. Our conclusions and suggestions on trazodone are guided by the 
observations on in vitro cultured ahNPC. Extended in vivo studies should confirm 
that increased ahNG is required for trazodone antidepressant effect. 
In conclusion, the main take home message is that ahNG is modulable by several 
factors. The principle findings are that astrocytes secrete molecules such as 
Lipocalin-2 to increase neuronal differentiation from ahNPC. We showed that 
intrinsic defects in astrocytes and ahNPC are caused by NF-κB p50 absence since 
astrocytes change their secretory profile and ahNPC receptors expression. We 
showed for the first time that ahNG is a pharmacological target for trazodone and 
that 5-HT2A/2C antagonism and 5-HT7 activation could be novel mechanisms that 
positively modulate ahNG. Finally, NF-κB transcription factors specifically the p50 
subunit play an important role in mediating astrocytes and antidepressants 
proneurogenic effects. 
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